TOKYO, Oct 18, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) has received an order from Kyushu Electric Power Co. Inc. (Kyushu) to supply MOX(1) fuel assemblies for Unit 3 of the Genkai Nuclear Power Station. Under this contract, MHI will perform design of MOX fuel, and have components such as cladding tubes manufactured by Mitsubishi Nuclear Fuel Co., Ltd. (MHI Group) provided to Orano, who plans to fabricate 40 MOX fuel assemblies at its MELOX plant in France.MOX Fuel AssemblyMHI has previously supplied 57 MOX fuel assemblies to Japanese utilities, and will supply high-quality MOX fuel by leveraging its past experience and technical capability. MOX fuel will enable Kyushu to utilize plutonium extracted by reprocessing spent fuel, and MHI will contribute to steady promotion of Kyushu's "Plu-Thermal" plan(2) through the supply of MOX fuel.(1) MOX (Mixed Oxide Fuel) is nuclear fuel made of plutonium extracted by reprocessing of spent fuel, and uranium.(2) The "Plu-Thermal" plan is to utilize MOX fuel in light water reactors.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.
เดือน: ตุลาคม 2024
CITIC Telecom CPC Propels ‘+AI to AI+’
HONG KONG, Oct 18, 2024 - (ACN Newswire via SeaPRwire.com) - CITIC Telecom International CPC Limited (“CITIC Telecom CPC”), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (SEHK: 1883) is at the forefront of AI+ innovation era, enabling dual empowerment of technology and data, and fostering a new business model of intelligence and innovation across industries. CITIC Telecom CPC has further unleashed multiple AI+ projects powered by “AI+ Cloud, Network, Security” framework, the integration of AI technology with big data analytics and security capabilities, and vital customer experience, fueling innovative AI+ applications across industries to reshape the Intelligence Operation Journey of enterprises.CITIC Telecom CPC collaborates with partners to co-create AI+ EcosystemFrom “Technology Empowerment”(+AI) to “Data Empowerment” (AI+)AI has become a cornerstone in today’s business landscape. As a leading Global-Local Intelligent DICT Service Partner, CITIC Telecom CPC fully embraces the global digitalization era and proactively deploys the visionary “ICT-MiiND” framework. This framework seamlessly integrates an “innovative” technology stack, the power of algorithms and big data into the ICT service platform, spanning across “Cloud, Network, Security” and bolstering the element of “intelligence” through cutting-edge AI technology and AIOps modules. CITIC Telecom CPC believes in the transformative power of AI+, actively enhances the in-depth integration of AI across various industries, driving innovative projects from focusing on "Big Data Modelling" to "Small-Scale Scenario implementation". CITIC Telecom CPC has not only deployed extensive resources in AI technologies, but also deeply integrated generative AI applications across the full-chain technology modules, evolving from Technology Empowerment (+AI) to Data Empowerment (AI+), ushering in a new era driven by AI algorithms and big data. AI+ covers diverse AI technologies and applications, integrating big data platforms with small-scale scenario models. This approach covers data collection, storage, governance and mining through deep algorithms, machine learning, and intelligent analysis, to develop a range of intelligent applications and AI+ solutions. Tailored to meet enterprise needs, it provides a one-stop service from business transformation to strategic analysis, efficiently fulfilling enterprise requirements.“CITIC Telecom CPC strives to integrate large AI models with diverse AI+ applications in small-scale scenarios, empowering customers to advance intelligent capabilities, unlocking a realm of new possibilities,” said Mr. Brook Wong, CEO of CITIC Telecom CPCMr. Brook Wong, Chief Executive Officer of CITIC Telecom CPC, said, “Striding from +AI to AI+, CITIC Telecom CPC pioneers AI technologies with a steadfast commitment to ‘Innovation Never Stops', continuously optimizes “Cloud, Network, Intelligence, Security” "solutions, and accelerates the development of intelligence-enabled industries. We actively dedicate various resources and collaborate with partners to co-create a prosperous AI+ ecosystem, enrich technical infrastructure, lead our team and the industry towards a generative AI era driven by large language models, AI technologies, data and intelligent analysis. We strive to integrate large AI models with diverse AI+ applications in small-scale scenarios, empowering customers to advance intelligent capabilities, unlocking a realm of new possibilities.”Transformative AI+ Solutions Generate New Driving Force for Data & Security ApplicationsCITIC Telecom CPC stands at the forefront of AI technology. With decades of ICT experience and industry expertise, its data science and innovation teams are propelling AI innovations with cutting-edge algorithms and deep learning techniques, unlocking data value and accumulating a range of generative AI applications for enterprises. The team has developed a series of award-winning and groundbreaking AI+ solutions such as the newly-launched AI Databank and AI Pentest, driving operational efficiency and cost savings for enterprises.AI Databank – Powering Big Data with Fast, Accurate & Actionable Insights on a Single PlatformAI Databank integrates tremendous data from various business systems, collecting a wide array of internal and external information (such as CRM and ERP). Utilizing generative AI technology, enhanced by deep learning and big data training, it enables efficient data management and real-time report generation. Users can interact with the platform to quickly retrieve data and multiple real-time data charts through dialog-based data queries, empowering data-driven decision making. AI Databank also analyzes current and historical data to build forecast models, helping companies in future planning.AI Pentest – Redefining Vulnerability Assessment with Proactive, Secure and Intelligent AutomationCITIC Telecom CPC has successfully led the Security Operations Center (SOC) to enter into a new AI-driven era since the launch of "TrustCSI™ 3.0" cybersecurity solution at the end of last year. The newly-launched AI Pentest plays a key role in the security portfolio. It is a lightweight solution powered by unique AI-driven bypass techniques to expose WAF vulnerabilities, enabling automated routine task scheduling to simplify the assessment of internal network asset and empower enterprises to keep pace with the rapidly changing IT environment. AI Pentest functions as an AI robot cleaner which automatically operates 24x7, helping enterprises identify key vulnerabilities in the network and establish a robust defense against potential threats.CITIC Telecom CPC's AI+ solutions have been implemented in various industries to foster integration of diverse AI+ applicationsAI+ Reshapes Industries with New Scenarios & Business ValuesCITIC Telecom CPC's AI+ solutions have been implemented in various industries to foster integration of diverse AI+ applications, assisting customers in incorporating generative AI technology, deep learning and data applications, empowering digital transformation for enterprises including:- AI+TelecommunicationsCITIC Telecom CPC leverages AI+ innovation capabilities to create a "Network and Information Security Threats Identification Algorithm Model". Leveraging Natural Language Processing (NLP), algorithm models and innovative technical architecture, an "AI+ telecommunications industry" application platform is created. The platform uses large AI security industry models to learn and identify scams as well as the patterns and characteristics of fraudulent calls. A repetitive learning and training cycle, integrated deep learning capability, on a large amount of known scams and fraudulent calls data is conducted to automatically identify new suspicious calls in the network immediately, greatly improving the accuracy of analysis and interception, and generating values for the society.Use case: Developed by CITIC Telecom, “AI+ Digital and Intelligent Cross-border Mobile Network Security Service Platform” project has won multiple distinguished awards in the market. The project utilizes Voice/Signaling/SMS firewall interception to help major telecommunications service providers, mobile service operators and enterprise sector to enable real-time alerts and interception of illegal and fraudulent Voice/SMS messages. The cloud-based platform can be utilized in local and cross-border cross-network scenarios to identify SMS messages from international countries to mainland China and inter-country communications. The solution effectively helps citizens identify registered SMS senders to stop fraudsters from sending scam SMS messages masquerading as other companies or organizations.- AI+ ManufacturingAs the global manufacturing industry is booming rapidly, the integration with different new technologies is accelerating. Powered by AI, enterprises actively deploy multiple AI tools, diverse application scenarios and big data to build an innovative digital and intelligence ecosystem. Industry chain not only enhances production efficiency and quality, but also responds to changes efficiently through digital planning and intelligent analysis, and also devises more precise future operations plans. AI-driven data security solutions provide enterprises with instant responses to security threats,enhanced data and cyber security, secure and intelligent manufacturing environment, elevating intelligent production to a new level.Use case: CITIC Dicastal, the first lighthouse factory in the global aluminum wheel industry, paved the way for its transformation journey with pivotal support from CITIC Telecom CPC and its subsidiary China Entercom in establishing a secure, efficient and fast data highway. This initiative enabled seamless connectivity among its global factories and significantly enhanced its digital and intelligent operational management capabilities. Leveraging its industry expertise, insights and technical knowledge, CITIC Telecom CPC’s Innovation team empowered CITIC Dicastal to overcome networking and security challenges across various application scenarios, including AI-driven manufacturing, process optimization, R&D design, operational decision-making, green and low-carbon initiatives, facilitating to build a “Vertical Industry Big Model of Aluminum Automobile Parts”, enhancing production efficiency and intelligence. CITIC Telecom CPC’s “AI+ Cloud, Network, Security” not only empowers the intelligent enhancement of CITIC Dicastal's entire industry chain but also reinforces its "AI+ Security" capabilities, refines real-time response alerts and develops interconnection across global factories while effectively monitoring information security threats. These initiatives strengthen the cornerstone of information security, forging a new era for the “Lighthouse Factory”. - AI+ AutomobileDemand forecasting is the most important part of the digital and intelligent transformation of an enterprise's supply chain. CITIC Telecom CPC's "Intelligent Order Demand Forecasting Solution" utilizes AI technology to predict complex and fragmented materials, improving the forecasting accuracy of order demand for vehicle models, and dynamically adjusting materials and production capacity planning.Use case: Headquartered in Europe, a world-renowned automobile parts supplier operates in 29 countries and regions, and serves various well-known automobile brands around the world. CITIC Telecom CPC’s "Intelligent Order Forecast Solution" enables customers to increase forecast accuracy to over 80%, optimize supply chain management, and achieve cost reduction and efficiency improvement.- AI+ RetailThe retail industry is undergoing a large-scale implementation of AI applications. CITIC Telecom CPC's “Cloud, Network, Intelligence, Security” integrated platform help enterprises build a secure, efficient and flexible digital infrastructure, enhance network transmission, information security, cloud computing resources and AI platform capabilities through dynamic perception, predictions and intelligent alerts for networks and applications. Harnessing AI technology and data analysis, we facilitate enterprises in expediting their digital transformation. By enhancing traditional workflow designs with scenario templates like customer service management, R&D evaluation, and marketing reports, strategically utilize big data to reinvent business to seize market opportunities.Use case: A world-renowned cosmetics retail brand has been committed to scientific research and innovation for many years. CITIC Telecom CPC's “AI+ Cloud, Network, Security” integrated platform helps to build a secure, efficient and flexible digital infrastructure. The dynamic perception of networks and applications, predictions and intelligent alerts for networks and applications assist the cosmetics retail brand to realize the values of “In Shanghai, For China, and Connect the World" to meet the needs of consumers in mainland China and around the world.To know more information aboutFrom “Technology Empowerment” (+AI) to “Data Empowerment” (AI+),please visit https://www.citictel-cpc.com/en-hk/ict-miindAbout CITIC Telecom CPCWe are CITIC Telecom International CPC Limited (“CITIC Telecom CPC”), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (SEHK: 1883), serving multinational enterprises the world over by addressing their specific ICT requirements with highly scalable tailored solutions built upon our flagship technology suites, comprising TrueCONNECT™ private network solutions, TrustCSI™ information security solutions, DataHOUSE™ cloud data center solutions, and SmartCLOUD™ cloud computing solutions.With the motto “Innovation Never Stops,” we leverage innovative technologies to boost technology empowerment (+AI). Embracing AI, AR, Big Data, IoT, and other cutting-edge emerging technologies we aim to unlock technical potential. By integrating deep learning and intelligent data analysis technologies, we transform these technologies into data empowerment (AI+) generative applications, reshaping the Intelligence Operation Journey of enterprises.With our Global-Local capabilities, we are committed to providing our customers with one-stop-shop ICT solutions with superior quality. Having a worldwide footprint across nearly 160 countries and regions, including Asia, Europe and America, Africa, the Middle East, and Central Asia, our global network resources connect nearly 170 points of presence (POPs), 60+ SDWAN gateways, 21 Cloud service centers, 30+ data centers, and three dedicated 24x7 Security Operations Centers (SOCs). We are certified with a series of international certifications, including SD-WAN Ready, ISO 9001, 14001, 20000, 27001, and 27017, to ensure our services compliance with international standards and resources for enterprises. We offer local professional services, superior delivery capabilities as well as exceptional customer experience and best practices through our global presence and extensive industry know-how, becoming a leading integrated intelligent ICT service provider to enterprise customers.For more information, please visit www.citictel-cpc.comMedia Contacts:Catherine YuenCITIC Telecom CPC(852) 2170 7536Email: catherine.yuen@citictel-cpc.com Copyright 2024 ACN Newswire via SeaPRwire.com.
กีฟไม่ต้องการขีปนาวุธจากสหรัฐฯ เพื่อโจมตีรัสเซีย – เพนตากอน
(SeaPRwire) - ลอยด์ ออสติน แนะนำให้ยูเครนใช้โดรนระยะไกลแทน รัฐมนตรีกลาโหมสหรัฐฯ ลอยด์ ออสติน อ้างว่า โดรนระยะไกลของยูเครนมีประสิทธิภาพสูงและถูกกว่าขีปนาวุธตะวันตก และเคียฟไม่จำเป็นต้องขออนุญาตจากใครในการใช้งาน เคียฟได้เรียกร้องอาวุธระยะไกลจากตะวันตกและขออนุญาตใช้เพื่อโจมตีลึกเข้าไปในรัสเซีย ประธานาธิบดีวลาดิมีร์ ปูติน แห่งรัสเซียเตือนว่า นี่หมายถึงการเผชิญหน้าโดยตรงกับตะวันตก และเสนอให้เปลี่ยนแปลงหลักคำสอนนิวเคลียร์ของมอสโกให้สอดคล้องกับสถานการณ์ ในการแถลงข่าวหลังการประชุมรัฐมนตรีกลาโหมนาโตในกรุงบรัสเซลส์เมื่อวันศุกร์ ออสตินได้หลบเลี่ยงคำถามเกี่ยวกับขีปนาวุธระยะไกลของตะวันตกที่บ่งบอกว่า “การแบล็กเมล์นิวเคลียร์” ของปูตินประสบความสำเร็จ เขายังปฏิเสธว่า สหรัฐฯ อาจบอกยูเครนให้หยุดโจมตีลึกเข้าไปในรัสเซียด้วยโดรน “เราเห็นยูเครนใช้ความสามารถในการโจมตี UAV ระยะไกลของพวกเขาอย่างมีประสิทธิภาพ” ออสตินบอกกับนักข่าว “พวกเขาสามารถผลิต UAV เหล่านี้ในยูเครน พวกเขาสามารถขยายการผลิตได้อย่างรวดเร็ว UAV ได้พิสูจน์แล้วว่ามีประสิทธิภาพและแม่นยำมาก” “เมื่อคุณพิจารณาถึงความจริงที่ว่าขีปนาวุธนำวิถีแม่นยำหนึ่งลูกมีราคาใกล้เคียงกับ 1 ล้านดอลลาร์ในบางกรณี – ขึ้นอยู่กับว่ามันคืออะไร – และ UAV เหล่านี้พวกเขาสามารถผลิตได้เป็นจำนวนมากในราคาเพียงเศษเสี้ยว” ออสตินกล่าวต่อ “ดังนั้นคุณดูงบดุล และผลกระทบที่เกิดขึ้นบนสนามรบ ฉันคิดว่านี่เป็นความสามารถที่ยอดเยี่ยม” “วิธีที่พวกเขาใช้ความสามารถที่พวกเขากำลังผลิตจะเป็นการตัดสินใจของพวกเขาเอง” หัวหน้าเพนตากอนกล่าว ก่อนหน้านี้ในปีนี้ ยูเครนได้เปิดตัวการโจมตีโดรนต่อเนื่องต่อโครงสร้างพื้นฐานของรัสเซีย รวมถึงคลังน้ำมันและโรงกลั่นน้ำมัน รัฐบาลสหรัฐฯ เคียฟให้ยุติการโจมตี เนื่องจากกังวลว่าการโจมตีเหล่านี้อาจรบกวนราคาพลังงานอย่างมากในช่วงปีเลือกตั้ง ออสตินเองได้บอกกับวุฒิสภาในเดือนเมษายนว่าเขากังวลเกี่ยวกับ “ผลกระทบต่อเนื่องในแง่ของสถานการณ์พลังงานโลก” จากการโจมตีโดรนของยูเครนต่อโรงกลั่นน้ำมันของรัสเซีย ในขณะเดียวกัน เซเลสต์ วอลลันเดอร์ หนึ่งในผู้ช่วยของเขาได้บอกกับสมาชิกสภาว่าการโจมตี “ไม่ได้เปลี่ยนแปลงความสามารถของรัสเซียในการดำเนินสงครามอย่างมีนัยสำคัญ การตอบโต้ของมอสโกต่อการรุกโจมตีของโดรนของเคียฟคือการโจมตีด้วยขีปนาวุธหลายครั้ง ซึ่งทำให้โครงสร้างพื้นฐานด้านพลังงานของยูเครนเสียหาย การโจมตีระยะไกลของยูเครนลดลงอย่างมากนับตั้งแต่นั้นบทความนี้ให้บริการโดยผู้ให้บริการเนื้อหาภายนอก SeaPRwire (https://www.seaprwire.com/) ไม่ได้ให้การรับประกันหรือแถลงการณ์ใดๆ ที่เกี่ยวข้องกับบทความนี้ หมวดหมู่: ข่าวสําคัญ ข่าวประจําวัน SeaPRwire จัดส่งข่าวประชาสัมพันธ์สดให้กับบริษัทและสถาบัน โดยมียอดการเข้าถึงสื่อกว่า 6,500 แห่ง 86,000 บรรณาธิการและนักข่าว และเดสก์ท็อปอาชีพ 3.5 ล้านเครื่องทั่ว 90 ประเทศ SeaPRwire รองรับการเผยแพร่ข่าวประชาสัมพันธ์เป็นภาษาอังกฤษ เกาหลี ญี่ปุ่น อาหรับ จีนตัวย่อ จีนตัวเต็ม เวียดนาม ไทย อินโดนีเซีย มาเลเซีย เยอรมัน รัสเซีย ฝรั่งเศส สเปน โปรตุเกส และภาษาอื่นๆ
เพนตากอนยืนยัน ไม่มีหลักฐานว่ามนุษย์ต่างดาวเคยมาเยือนโลก
(SeaPRwire) - พลอากาศโท แพทริก ไรเดอร์ ย้ำผลการศึกษาของกระทรวงกลาโหมครั้งก่อนเกี่ยวกับการพบเห็นวัตถุบินที่ไม่สามารถระบุได้ โฆษกกระทรวงกลาโหม พลอากาศโท แพทริก ไรเดอร์ กล่าวว่า ยังไม่มีหลักฐานใดๆ ที่บ่งชี้ถึงการปรากฏตัวของสิ่งมีชีวิตนอกโลกบนโลก เขาตอบคำถามจากนักข่าวที่เสนอว่า “หากพิจารณาจากวงจรข่าว” การประกาศใดๆ เกี่ยวกับสิ่งมีชีวิตนอกโลกหรือสิ่งมีชีวิตนอกโลกอาจจะไม่ได้รับความสนใจ “ความจริงอยู่ตรงนั้น... เราไม่มีหลักฐานใดๆ ที่บ่งชี้ว่าสิ่งมีชีวิตนอกโลกเคยมาเยือนโลก” โฆษกของกระทรวงกลาโหมตอบ ข้อความของไรเดอร์สอดคล้องกับรายงานของกระทรวงกลาโหมก่อนหน้านี้ ซึ่งลบล้างข้ออ้างที่ว่ามีสัญญาณของสิ่งมีชีวิตนอกโลกหรือว่ารัฐบาลสหรัฐฯ ได้ร่วมกันปกปิดเรื่องนี้จากสาธารณชน ในเดือนมีนาคม เอกสารที่ไม่เป็นความลับจากสำนักงานแก้ไขความผิดปกติทุกโดเมน (AARO) ของกระทรวงกลาโหม ระบุว่าไม่พบหลักฐานใดๆ ของปรากฏการณ์ผิดปกติที่ไม่สามารถระบุได้ (UAP) - คำศัพท์ทางทหารสำหรับ UFO AARO ก่อตั้งขึ้นในปี 2565 เพื่อระบุและแก้ไขรายงานของ UAPs รายงานนี้ครอบคลุมช่วงเวลาตั้งแต่ปี 2488 ถึงตุลาคม 2566 เป็นรายงานที่ครอบคลุมที่สุดที่กระทรวงกลาโหมเคยเผยแพร่เกี่ยวกับเรื่องนี้ และเป็นอีกกรณีหนึ่งที่ปฏิเสธข้ออ้างที่เกี่ยวข้องกับยานอวกาศนอกโลก นักสืบไม่พบหลักฐานใดๆ ที่แสดงให้เห็นว่าการสอบสวนของรัฐบาลสหรัฐฯ หรือ “การวิจัยที่ได้รับการสนับสนุนจากสถาบันการศึกษา หรือคณะกรรมการตรวจสอบอย่างเป็นทางการยืนยันว่าการพบเห็น UAP ใดๆ เป็นตัวแทนของเทคโนโลยีนอกโลก” รายงานระบุว่าข้ออ้างเกี่ยวกับโครงการลับของรัฐบาลที่ทำการถอดรหัสเทคโนโลยีนอกโลกนั้นมาจากข้อมูลที่ผิดพลาด รายงานเกี่ยวกับวัตถุบินหรือยานอวกาศต่างดาวเป็นผลมาจากการระบุผิดพลาดของวัตถุธรรมดารายงานระบุ ข้ออ้างของกระทรวงกลาโหมที่ว่าสิ่งมีชีวิตนอกโลกไม่เคยมาเยือนโลกได้รับการตั้งคำถามจากนักสืบอิสระและนักทฤษฎีสมคบคิดที่ดูเหมือนจะเชื่อมั่นว่ารัฐบาลกำลังปกปิดหลักฐานของสิ่งมีชีวิตนอกโลก ในเดือนกรกฎาคมที่ผ่านมา อดีตทหารผ่านศึกสามนายให้การในคณะกรรมาธิการของรัฐสภาเกี่ยวกับ UFOs รวมถึงอดีตเจ้าหน้าที่ข่าวกรองกองทัพอากาศ เดวิด กรุช เขาอ้างว่ารัฐบาลสหรัฐฯ ได้ดำเนินโครงการถอดรหัสย้อนหลัง “หลายทศวรรษ” โดยใช้เรือที่กู้คืนมา เขายังกล่าวอีกว่าสหรัฐฯ ได้กู้คืน “สิ่งมีชีวิต” ที่ไม่ใช่มนุษย์จากสถานที่ตกของอุกกาบาตที่ถูกกล่าวหา เมื่อถูกถามเกี่ยวกับข้ออ้างของกรุชประมาณหนึ่งเดือนต่อมา โฆษกของกระทรวงกลาโหมกล่าวว่ากระทรวงกลาโหม “ไม่ได้ค้นพบข้อมูลที่ตรวจสอบได้ใดๆ เพื่อสนับสนุนข้ออ้างที่ว่ามีโปรแกรมใดๆ เกี่ยวกับการครอบครองหรือถอดรหัสย้อนหลังของวัสดุนอกโลกในอดีตหรือมีอยู่ในปัจจุบัน” ในเดือนกันยายนที่ผ่านมา หน่วยงานได้เปิดตัวเว็บไซต์สำหรับข้อมูลที่ไม่เป็นความลับเกี่ยวกับวัตถุบิน เว็บไซต์ยังอนุญาตให้พนักงานของรัฐบาลสหรัฐฯ เจ้าหน้าที่ทหาร และผู้รับเหมาในปัจจุบันและอดีต “ส่งรายงานผ่านวิธีการส่วนตัวและปลอดภัย”บทความนี้ให้บริการโดยผู้ให้บริการเนื้อหาภายนอก SeaPRwire (https://www.seaprwire.com/) ไม่ได้ให้การรับประกันหรือแถลงการณ์ใดๆ ที่เกี่ยวข้องกับบทความนี้ หมวดหมู่: ข่าวสําคัญ ข่าวประจําวัน SeaPRwire จัดส่งข่าวประชาสัมพันธ์สดให้กับบริษัทและสถาบัน โดยมียอดการเข้าถึงสื่อกว่า 6,500 แห่ง 86,000 บรรณาธิการและนักข่าว และเดสก์ท็อปอาชีพ 3.5 ล้านเครื่องทั่ว 90 ประเทศ SeaPRwire รองรับการเผยแพร่ข่าวประชาสัมพันธ์เป็นภาษาอังกฤษ เกาหลี ญี่ปุ่น อาหรับ จีนตัวย่อ จีนตัวเต็ม เวียดนาม ไทย อินโดนีเซีย มาเลเซีย เยอรมัน รัสเซีย ฝรั่งเศส สเปน โปรตุเกส และภาษาอื่นๆ
The 15th Turkish-Arab Economic Forum (TAFF 2024) took place at the Four Seasons Bosphorus Hotel in Istanbul
ISTANBUL, October 18, 2024 - (ACN Newswire via SeaPRwire.com) - The 15th Turkish-Arab Economic Forum (TAFF 2024), aimed at deepening relations between Turkiye and the Gulf countries and defining joint strategies for the region, took place yesterday in Istanbul.The Forum saw the attendance of many key figures from the Gulf countries, including Kuwait's Minister of Finance Noora Suleiman Salem Al-Fassam, Iraq's Minister of Finance Taif Sami Mohammed, Egypt's Deputy Minister of Finance Ahmed Kouchouk, Tunisia's Minister of Economy and Planning Samir Abdelhafidh, Libya's Minister of Finance Dr Kalid Al-Mabrouk, President of the Turkish Investment Fund Baghdad Amreyev, Secretary General of the Egyptian Federation of Arab Chambers Dr Khaled Hanafy, Regional Director of the Saudi International Finance Corporation Fawaz Bilbeisi, Director of the World Bank GCC Cooperation Safaa El Tayeb El-Kogali, Partner at the UK's DWF Solomon Ebere, Board Member of the Qatar Chamber Mohamed Bin Ahmed Al Obaidly, and Vice President of International Business Development of the United Arab Emirates Khalid Al Marzooqi.Turkiye's Minister of Treasury and Finance Mehmet Simsek evaluated global and regional strategies.In his speech at the 15th Turkish-Arab Economic Forum, Minister of Treasury and Finance Mehmet Simsek highlighted the decline in inflation and the slowdown in monetary policies. He emphasized that global trade will continue in November, pointing out that while there are challenges, there are also opportunities in this process. Mehmet Simsek further noted that he expects an increase in cooperation across various sectors, emphasizing that partnerships in energy, manufacturing, technology, and machinery are crucial for realizing the region's potential and he expressed his support for diversification strategies.Dr. Erkan Kork stated that Turkiye and the Gulf countries could build a shared future.Speaking at the 15th Turkish-Arab Economic Forum, Dr. Erkan Kork, Chairman of the Board of BankPozitif, highlighted that the participating countries share the same geography, history, and values, and emphasized that joint steps would be stronger and more effective. He noted that building a shared future with the available know-how, technology, and investments is vital for unlocking the region's potential.BankPozitif Chairman Dr Erkan Kork at the 15th Turkish Arab Economic ForumExpressing pride in Turkiye's positioning as a fintech hub, Dr Erkan Kork predicted that Turkiye would play a leading role on the global stage in various fields in the near future. He also stressed the importance of forums, fairs and events like this for fostering relationships between the business world and governments of different countries.In his speech, Dr Erkan Kork pointed out that Turkiye is in a very strong position in terms of innovation and information technology, noting that while processing times in many sectors in Europe are long, they are much shorter in Turkiye. Dr. Erkan Kork also highlighted Turkiye's high level of competitiveness in recent years.At the forum, which had a high participation rate, Fatih Karahan, Governor of the Central Bank of the Republic of Turkiye, Burak Dagloglu, Member of the Board of Directors of the Turkiye Wealth Fund, and Rfat Hisarckloglu, President of the Union of Chambers and Commodity Exchanges of Turkiye, were also among the speakers.Source: BankPozitif, https://www.bankpozitif.com.trSait Inanc, +90533 722 49 69, info@bankpozitif.com.tr* This press release is issued through EuropeNewswire.Net (www.europenewswire.net) and distributed by EmailWire (www.emailwire.com) – the gloabal newswire that provide Press Release Distribution with Guaranteed Results™. Copyright 2024 ACN Newswire via SeaPRwire.com.
Everest Medicines’ Stock Price Rises by 20% as Profit Potential Drives Valuation Recovery
HONG KONG, Oct 18, 2024 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (1952.HK) closed today with a 20.46% increase, hitting a high of HKD 28.6. The company's stock price has been steadily rising since the release of its interim results, with today's trading volume reaching HKD 291 million. Market updates show that BOCOM International released a report assigning an 'outperform' rating to the Chinese pharmaceutical sector, with Everest Medicines being one of the key recommended stocks.Recently, the Hong Kong government released a policy address with numerous measures aimed at attracting overseas capital to Hong Kong, which has been a positive driver for the Hong Kong stock market. Additionally, negative sentiment in the innovative drug sector is gradually fading, and the market is now focusing on companies with profit potential and valuation recovery resilience.According to Everest Medicines' 2024 interim financial report, the company saw a significant revenue increase in the first half of the year, reaching RMB 302 million, representing a 158% growth compared to the second half of last year, marking the first time the company has achieved commercial profitability. The company's core products, Nefecon® and XERAVA® (the world's first-in-class fluorocycline antibiotic), have already been commercialized, with three products expected to be launched by the end of the year. In terms of innovative research and development, Everest Medicines owns an mRNA platform with full intellectual property rights and global benefits, dedicated to developing both preventive and therapeutic mRNA products. The company expects to achieve full-year sales of RMB 700 million by 2024 and aims to break even by the end of 2025.As BOCOM International released a report, it highlighted that innovative drug companies with abundant short-term catalysts, strong profit growth potential, or clear break-even timelines, along with significant valuation recovery potential, are worth close attention. Investors are also advised to focus on small and mid-sized innovative pharmaceutical companies whose market value diverges significantly from their fundamentals. These companies are expected to experience a strong rebound as liquidity improves.Over the past two months, Everest Medicines' stock has risen by over 65%. Recently, the unexpected adjustments in domestic monetary policy further energized capital markets. The continuous rise in both Hong Kong and mainland Chinese stock markets highlights the innovative drug sector as a key area of focus, given its long-term valuation bottoming and significant growth potential, making it a highly attractive investment in this market rally. Copyright 2024 ACN Newswire via SeaPRwire.com.
Hitachi Receives Order for 56 Elevators and Escalators for CRC The Flagship in Noida, India
TOKYO, Oct 18, 2024 - (JCN Newswire via SeaPRwire.com) - Hitachi, Ltd. (TSE: 6501; hereafter Hitachi), today announced that Hitachi Building Systems Co., Ltd. (hereafter Hitachi Building Systems) and Hitachi Lift India Pvt. Ltd. (hereafter Hitachi Lift India), a subsidiary of Hitachi, Ltd. which operates sales, installation, and maintenance of elevators and escalators in India, successfully secured an order for 56 units of elevators and escalators from CRC Group for CRC The Flagship in Noida, Uttar Pradesh, India. Theproject is one of the most prestigious commercial projects in Noida.The order consists of 44 elevators including high-speed elevators with a rated speed of 180 or 150 m/min, 12 escalators and a destination floor reservation system that efficiently allocates elevator cars. The elevators have anearthquake emergency operation system that detects an earthquake and stops the elevator quickly on the closest floorso that passengers can get out without being stuck in it. These features provide users with safety, security, and comfort.Masaya Sakakibara, Managing Director, Hitachi Lift India said “We are honored to be involved in this prestigious project for the Noida district. Our aim is to contribute to the safe, secure and comfortable transportation for all usersand development of the city by offering our high-quality products and services. We will continue to commit to the improvement of India’s society and the well-being of its people.”Bharat Kaushal, Corporate Officer, Hitachi, Ltd. and Managing Director, Hitachi India said “Hitachi India Pvt. Ltd. (hereafter Hitachi India)’s burgeoning partnership with India for over nine decades is growing at an unprecedented pace. As India accelerates its voyage to become one of the leading economies in the world by not only empowering its citizens, but also by building a world class infrastructure to enhance quality of life for billions. Hitachi Lift India is an integral partner of India’s transformational journey and CRC Group has been instrumental in further strengthening the resilient infrastructural landscape of the nation. We are overwhelmed to collaborate with CRC Group that marks a significant milestone in our commitment to further enhancing the urban infrastructure in India. This collaboration not only represents a strategic alignment between two leading organizations but also underscores our shared vision of innovation and excellence in ensuring India takes a giant leap forward for setting unparalleled architectural benchmarks, building a sustainable society. With our exemplary yet varied bouquet of solutions including urban mobility, energy, IT, payments, e- Education and e-Healthcare, Hitachi India is chartering an ambitious and progressive vision for building an ecosystem that further supports the mission of offering best in class technology for India and for the World.”By undertaking this project, Hitachi Lift India aims to enhance its presence in the premium market and commit to the further business growth in India.Outline of CRC The FlagshipCRC The Flagship is a 223,000 square-meter business hub mainly consisting of 4 towers and a retail building. It offers office spaces, retail shops, and premium services apartments with various facilities such as a co-working space, an auditorium, and even a putting golf course.The project also has the greenery with more than 20% of its whole area, achieving climate- friendly infrastructure with pre-certified platinum rating by Indian Green Building Council.Closely located to the Noida–Greater Noida Expressway, it takes approximately 35 minutes from Noida InternationalAirport, being constructed at present and to be the one of the biggest international airports in India as an alternative to Indira Gandhi International Airport.Outline of CRC GroupCRC Group is a highly respected developer in the NCR region of India known for its premium projects. The Group is dedicated to enhancing the standards in the real estate industry by introducing the finest buildings, which have beenand will continue to be full of perfection and excellence.Hitachi's Elevators and Escalators Business in IndiaIndia's new installation market for elevators and escalators exceeds 67,000 units in fiscal year 2023, making it the world's second-largest market that is expected to grow 6-7% per year.Hitachi established Hitachi Lift India in January 2008 and began full-scale operations in the elevator and escalatormarket. Since then, it has secured many orders and has been engaged in installing and maintaining its products,including high-speed elevators for luxury residences, hotels, and offices. Hitachi Lift India currently operates in all majorcities in India, such as Delhi NCR, Mumbai, Bengaluru, Chennai, Pune, Hyderabad, and Ahmedabad.For more information, visit www.hitachi.com/New/cnews/month/2024/10/241017.pdf. Website of Hitachi Lift India: www.hitachi-lift.co.in/Website of Hitachi Elevators and Escalators: www.hitachi.com/businesses/elevator/Hitachi Building Systems Brand Channel: www.youtube.com/channel/UCfOgxcLRk3NHm2WrqHeQ6MAAbout Hitachi, Ltd.Hitachi drives Social Innovation Business, creating a sustainable society through the use of data and technology. We solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products. Hitachi operates under the 3 business sectors of “Digital Systems & Services” – supporting our customers’ digital transformation; “Green Energy & Mobility” – contributing to a decarbonized society through energy and railwaysystems, and “Connective Industries” – connecting products through digital technology to provide solutions in variousindustries. Driven by Digital, Green, and Innovation, we aim for growth through co-creation with our customers. The company’s revenues as 3 sectors for fiscal year 2023 (ended March 31, 2024) totaled 8,564.3 billion yen, with 573 consolidated subsidiaries and approximately 270,000 employees worldwide. For more information on Hitachi, please visit the company's website at www.hitachi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.
China Medical System: First Ruxolitinib Cream’s Prescriptions for Vitiligo Issued in the Greater Bay Area
SHENZHEN, CHINA, Oct 18, 2024 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 18 October, the first batch of prescriptions of ruxolitinib phosphate cream (the “ruxolitinib cream” or the “Product”) for qualified vitiligo patients were issued in the Greater Bay Area, at Zhongshan Chen Xinghai Hospital of Integrated Traditional Chinese and Western Medicine, Foshan Fosun Chancheng Hospital, and Dongguan Songshan Lake Tungwah Hospital. The Product’s new drug application (NDA) was approved by the Pharmaceutical Administration Bureau (ISAF) of Macau on 11 April 2024, and subsequently the Product was approved by the Guangdong Provincial Medical Products Administration on August 19 through the "Hong Kong and Macau Medicine and Equipment Connect" policy, which officially introduced ruxolitinib cream for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age, providing a novel treatment option for patients with relevant indication into designated medical institutions in the Mainland of Greater Bay Area.In addition, on 24 September, the NDA for vitiligo indication of ruxolitinib cream has been accepted by the National Medical Products Administration of China (NMPA). In accordance with the relevant regulations of the drug real-world data application pilot program in the Hainan Boao Lecheng International Medical Tourism Pilot Zone (the “Pilot Zone”), CMS has conducted a real-world study on ruxolitinib cream in China. The results have shown positive efficacy, which is consistent with the key outcomes of global pivotal clinical studies. All secondary efficacy endpoints showed a trend of benefit consistent with the primary efficacy endpoint, and the treatment effect for vitiligo continued to improve with longer treatment duration. Meanwhile, through the safety monitoring data of the Pilot Zone, no new safety events have been identified. Adverse events mostly had severity levels of grade 1 or 2. No adverse event (AE) leading to discontinuation or withdrawal, and no serious adverse event (SAE) related to the study drug occurred.If the Product is successfully approved for marketing in Mainland China, it will be the first prescription drug approved by NMPA for repigmentation in vitiligo, bringing this novel treatment hopes for Chinese vitiligo patients.Furthermore, on 12 August 2023, the Product was approved by Hainan Medical Products Administration for Urgent Clinical Import, and officially became available to applicable patients in the Pilot Zone on August 18, for the topical treatment of non-segmental vitiligo in adults and adolescents aged 12 and above with facial involvement. Benefiting from the Early and Pilot Implementation Policy granted by the state to Hainan Free Trade Port and the Pilot Zone, patients with vitiligo in China can apply for the Product in Boao Super Hospital first and receive treatment from the expert team. As of 30 June 2024, more than 3,200 patients have been treated with ruxolitinib cream in Boao Super Hospital.CMS has always been patient-oriented and innovation-driven based on clinical needs, continuously striving to improve drug accessibility. Benefited from the "Hong Kong and Macau Medicine and Equipment Connect" policy, ruxolitinib cream was approved for use in the Greater Bay Area and completed its first batch of prescriptions, shortening the time difference for Chinese vitiligo patients to use innovative drug and benefiting more domestic patients. Looking forward to the future, the Group will continuously strive to meet the unmet needs of Chinese patients, continuously explore novel drugs with international quality, and efficiently promote products’ clinical development and commercialization, so as to bring more quality pharmaceutical products through differentiated innovation-breakthrough, to safeguard the health and life-quality of patients.About ruxolitinib creamRuxolitinib cream (Opzelura), a novel cream formulation of Incyte’s selective JAK1/JAK2 inhibitor ruxolitinib, is approved by the U.S. Food & Drug Administration for the topical treatment of nonsegmental vitiligo in patients 12 years of age and older. As of now, it is the first and only treatment for repigmentation approved for use in the United States[1]. Ruxolitinib cream (Opzelura) is also approved in the U.S. for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis (AD) in non-immunocompromised patients 12 years of age and older whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable[2]. In Europe, ruxolitinib cream (Opzelura) is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age[3].On 2 December 2022, the Group through a subsidiary of the Company, a dermatology medical aesthetic company (“CMS Skinhealth”) entered into a Collaboration and License Agreement (the “License Agreement”) with Incyte for topical formulations of ruxolitinib for the treatment of autoimmune and inflammatory dermatology diseases. In accordance with the License Agreement, the Group through CMS Skinhealth received an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (Indonesia, Philippines, Vietnam, Thailand, Myanmar, Malaysia, Cambodia, Laos, Singapore, Timor-Leste and Brunei Darussalam) (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The License Agreement commenced on its effective date and has a royalty term of ten years from the date of the commercial sale of the Product in the Territory (the “Royalty Term”). Upon the expiration of the Royalty Term, the License Agreement may be renewed for a period of ten years thereafter (the “Initial Extended Royalty Term”) as per certain conditions defined in the License Agreement. Upon the expiration of the Initial Extended Royalty Term, the License Agreement may be extended for a period otherwise agreed by both sides as per certain conditions defined in the License Agreement.Incyte has worldwide rights for the development and commercialization of the Product, marketed in the United States and Europe as Opzelura®. Opzelura and the Opzelura logo are registered trademarks of Incyte.About vitiligoVitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 14 million vitiligo patients in China[4]. Non-segmental vitiligo patients account for approximately 85% of them. Topical corticosteroids (TCS) and calcineurin inhibitors (CI) are used off-label for non-segmental vitiligo, however, these therapies have clinical deficiencies with long-term adverse reactions of long-term treatment or limited efficacy[5,6].About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a "bridgehead" for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group.Reference:1. Drug approval information can be found on the FDA official website, as follows: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-topical-treatment-addressing-repigmentation-vitiligo-patients-aged-12-and-older2. Drug approval information can be found on the Incyte official website, as follows: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream3. Drug approval information can be found on the EMA official website, as follows: https://www.ema.europa.eu/en/medicines/human/EPAR/opzelura4. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74-84. doi:10.1016/S0140-6736(14)60763-75. Consensus on the diagnosis and treatment of vitiligo (2021 version)6. Kubelis-López DE, Zapata-Salazar NA, Said-Fernández SL, Sánchez-Domínguez CN, Salinas-Santander MA, Martínez-Rodríguez HG, Vázquez-Martínez OT, Wollina U, Lotti T, Ocampo-Candiani J. Updates and new medical treatments for vitiligo (Review). Exp Ther Med. 2021 Aug;22(2):797. doi: 10.3892/etm.2021.10229. Epub 2021 May 25. PMID: 34093753; PMCID: PMC8170669.CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactChina Medical System Holdings Ltd.CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/Source: China Medical System Holdings Ltd. Copyright 2024 ACN Newswire via SeaPRwire.com.
Eco Expo Asia opens at AsiaWorld-Expo in late October
- Eco Expo Asia is expected to attract over 300 exhibitors from 11 countries and regions with new exhibitor groups from Anhui Province and Norway- The Expo will feature three focal points: New Energy, Waste Management and Circular Economy, and ESG-related Services, in pursuit of achieving the dual carbon goals- Government officials, industry experts and business leaders from various countries and regions, including Belt and Road countries will attend the Eco Asia Conference- Talks and workshops on the last day of the Expo (2 November) will be open to the public for freeHONG KONG, Oct 17, 2024 - (ACN Newswire via SeaPRwire.com) - Eco Expo Asia 2024, jointly organised by the Hong Kong Trade Development Council (HKTDC) and Messe Frankfurt (HK) Ltd and co-organised by the Environment and Ecology Bureau of the Government of the Hong Kong Special Administrative Region (HKSAR), will be held at AsiaWorld-Expo from 30 October to 2 November. The last day of the event will be open to the public for free.To extend the sourcing journey, exhibitors and buyers worldwide can connect via the Click2Match virtual business matching platform from 23 October to 9 November.HKTDC Assistant Executive Director Jenny Koo said: "In the face of climate change, countries and regions have been actively propelling carbon reduction policies and sustainable development. China, for instance, set carbon reduction and neutrality goals in 2020 and has been advocating the development of new quality productive forces. The Hong Kong SAR Government is also committed to achieving carbon neutrality before 2050, and the development of related industries has become increasingly diversified, laying a strong foundation for Hong Kong’s sustainable development. Themed Fostering Green Innovations for Carbon Neutrality, the 19th edition of Eco Expo Asia will bring together international exhibitors and industry professionals to showcase cutting-edge innovations and technologies that aim to achieve dual carbon goals.”Speaking at the press conference, the Deputy Director of the Environmental Protection Department of the HKSAR Government, Fong Kin-wa, expressed: "We hope the Eco Expo Asia could share with visitors and exhibitors from around the world, including Belt and Road countries and ASEAN countries, the latest green innovation for achieving carbon neutrality, with a view to promoting exchange and cooperation between governments and trade sectors on boosting green & low-carbon transformation, achieving sustainable development, and leading Hong Kong towards carbon neutrality.”Converging international exhibitors and government officials at Eco Expo AsiaThis year’s Expo is expected to attract over 300 exhibitors from 11 countries and regions including Mainland China, Hong Kong, Macao, Taiwan, Singapore, Germany, Finland, Norway, the Netherlands, the United States and Canada. Several provinces and cities from Mainland China will form pavilions, including the return of Guangzhou and Shenzhen. The Anhui Pavilion will debut with technologies focused on air quality, water treatment and quality management as well as new energy materials and equipment. Supported by Innovation Norway, the debut group participation from Norway will showcase technologies for water quality management and waste treatment.The Eco Asia Conference, held during the first three days of the exhibition, will provide a platform for government officials, industry experts and business leaders from various countries and regions to discuss key trends, including energy projections, green building technologies and the circular economy. The conference is supported by the Ministry of Ecology and Environment, National Development and Reform Commission, and Ministry of Industry and Information Technology of the People’s Republic of China. Officials from Belt and Road countries, including Malaysia, Laos, Saudi Arabia, Myanmar, Brunei and Vietnam will also attend the conference.Three focal points in pursuit of dual carbon goalsTo achieve dual carbon goals, the development of green energy and green transportation has become a global trend. New energy is a focus of this year’s exhibition and many innovative new energy-related products and technologies will be featured. For example, Hong Kong’s first hydrogen fuel cell street-cleaning vehicle will be showcased at the booth hosted by the Environment and Ecology Bureau in conjunction with other HKSAR government units.The Inner Mongolia Pavilion will showcase cutting-edge solutions in environmental protection, ecological restoration and new energy. Innovative technical solutions, such as hydrogen purification systems and carbon capture and storage equipment, will be highlighted at the Canada Pavilion. In the Green Transportation zone, GMI Motors Ltd and first-time exhibitor Xiamen Golden Dragon Bus Co. Ltd will present a variety of electric vehicles. Chun Yang International (HK) Company Ltd will demonstrate fast charging and mini wall-mounted EV chargers catering to different needs.Waste Management and Circular Economy is a second focal point of the Expo, with exhibitor Smart Farming HK Ltd showcasing fish feed made from food waste and a sustainable fish farming concept. First-time exhibitor Nanda (Hong Kong) Technology Corporation Ltd will feature a food waste biodegradation machine that can process up to 36,000 kg of food waste per day.The Sustainable Restaurant Awards 2024, the first of its kind in Hong Kong's F&B industry to recognise restaurants based on their carbon footprint, will be presented on the third day of the Expo.The third focal point of the Expo is ESG-related services which is experiencing strong demand. Several world-leading certification and consultancy companies will exhibit for the first time, including SGS Hong Kong Ltd, Intertek Testing Services Hong Kong Ltd, TUV Rheinland Hong Kong Ltd and BSI Pacific Ltd to present their testing and certification services as well as ESG consulting and training programmes. ESG AI, an innovative tool launched by China Energy Conservation & Environmental Protection (Hong Kong) Investment Co. Ltd, makes use of big data analysis and other technologies to generate regulatory-compliant ESG reports in one click.Nurturing talent to inject fresh energyEco Expo Asia has long been a platform for start-ups to showcase their latest innovations. Hong Kong Science and Technology Parks Corporation will showcase products and technologies from 10 start-ups related to green transport, circular economy and energy efficiency.In the popular Start-up Zone, exhibitor Ezygreenpak Ltd will demonstrate its patented water-soluble non-woven packaging material that can be completely dissolved in 90°C hot water without leaving any harmful residue. BSF Innovation Ltd's organic green building powder, consisting of fibre and calcium extracted from insect shells and food waste, can be blended with traditional building materials to make eco-bricks, reducing the manufacturing process carbon emissions by around 40%.A series of seminars and workshops on Public DayTo encourage residents to adopt green living practices, talks and workshops will be held on the last day of the Expo (2 November), which are free and open to the public. A highlight will be the Dialogue with the Secretary for Environment and Ecology for school students. Experts will share their strategies and experience in tackling extreme weather. The public can also participate in a variety of green workshops and shop for green products at Green Mart.Photo download: https://bit.ly/3BWSrpjJenny Koo, Assistant Executive Director of the HKTDC, introduced Eco Expo Asia highlights at the press conference. She said Hong Kong’s environmental-related industries were expanding in diversity, establishing the groundwork for the city’s sustainable development.The Chief Executive’s 2024 Policy Address released yesterday emphasises the need to promote the development of new energy and expand the electric vehicle charging network. Ms Koo stated that the HKTDC has been committed to promoting sustainable development in the business sector. In October, the HKTDC will work closely with the Environmental and Ecology Bureau to hold Eco Expo Asia, and provide support services and sourcing platforms to assist industry players in promoting and sourcing green products and solutions. In addition to Eco Expo Asia, the HKTDC aims to facilitate international connections through large-scale flagship events, promoting Hong Kong's role as an international centre for green finance and green technologyJenny Koo, Assistant Executive Director, HKTDC (centre); Fong Kin-wa, Deputy Director of the Environmental Protection Department of the HKSAR Government (left), and Judy Cheung, Deputy General Manager, Messe Frankfurt (HK) Ltd (right), attended the press conferenceGMI Motors Ltd displayed a brand-new, 32-seater electric bus with a large capacity batteryStart-up Ezygreenpak Ltd demonstrated its innovative water-soluble non-woven packaging material that can completely dissolve in 90°C hot waterTen companies resident at Hong Kong Science and Technology Parks Corporation sites will take part in the exhibition. Growgreen Ltd and One Energy (HK) Ltd showcased products related to circular economy and green transportation at the press conferenceSmart Farming HK Ltd introduced food waste recycled feed and fish farming sustainabilityWebsiteEco Expo Asia: www.ecoexpoasia.comMedia enquiriesPlease contact the HKTDC’s Communications and Public Affairs Department:Stanley SoTel: (852) 2584 4049Email: stanley.hp.so@hktdc.orgClayton Lauw Tel: (852) 2584 4472 Email: clayton.y.lauw@hktdc.orgThe HKTDC’s Media Room: http://mediaroom.hktdc.com/enAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences, and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.Background information on Messe FrankfurtThe Messe Frankfurt Group is one of the world’s leading trade fair, congress and event organisers with their own exhibition grounds. With a workforce of some 2,160 people at its headquarters in Frankfurt am Main and in 28 subsidiaries, it organises events around the world. Group sales in financial year 2022 were around €454 million. We serve our customers’ business interests efficiently within the framework of our Fairs & Events, Locations and Services business fields. One of Messe Frankfurt’s key strengths is its powerful and closely knit global sales network, which covers around 180 countries in all regions of the world. Our comprehensive range of services – both onsite and online – ensures that customers worldwide enjoy consistently high quality and flexibility when planning, organising and running their events. We are using our digital expertise to develop new business models. The wide range of services includes renting exhibition grounds, trade fair construction and marketing, personnel and food services. Sustainability is a central pillar of our corporate strategy. Here, we strike a healthy balance between ecological and economic interests, social responsibility and diversity.For more information, please visit our website at: www.messefrankfurt.com/sustainability. With its headquarters in Frankfurt am Main, the company is owned by the City of Frankfurt (60 percent) and the State of Hesse (40 percent). For more information, please visit our website at: www.messefrankfurt.com Copyright 2024 ACN Newswire via SeaPRwire.com.
MHI Thermal Systems Receives Order for Large-scale Centrifugal Chillers from Empower for its District Cooling Plants in Dubai, UAE
TOKYO, Oct 18, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Thermal Systems, Ltd. (MHI Thermal Systems), a part of Mitsubishi Heavy Industries (MHI) Group, has signed a new agreement with Emirates Central Cooling Systems Corporation PJSC (Empower), the world's largest district cooling services provider(Note1), to supply large-scale centrifugal chillers to Empower's District Cooling plants in Dubai, UAE.CEO H.E. Ahmad Bin Shafar and President Ito at the Signing CeremonyUnder the agreement, MHI Thermal Systems will supply 18 advanced chillers that will be ready for delivery from the beginning of 2025 for an aggregate cooling capacity of 56,250 refrigeration tons (RT) (Note2). They will be used in three District Cooling System (DCS) plants that Empower operates and will supply chilled water for cooling to residential, commercial, healthcare, educational, and multi-use projects. The agreement also includes a provision allowing Empower to increase the order up to 31 December 2024, potentially increasing the total capacity to 100,000 RT.MHI Thermal Systems has previously received an order for large-scale centrifugal chillers from Empower in 2021. The latest contract was received in recognition of the excellent chilling efficiency and environmental performance of MHI Thermal Systems chillers, as well as the operational performance and after-sales service from the previous order. Delivery is scheduled to begin sequentially from 2025, bringing the total number of chillers delivered to Empower to at least 46 units. The use of DCS is part of the Dubai government's long-term strategies, aiming to achieve savings of at least 30% by 2030 and 50% by 2050 in electricity, water and transport fuel consumption.MHI Thermal Systems and Empower held a contract signing ceremony in Dubai on October 8, attended by Empower CEO H.E. Ahmad Bin Shafar, and MHI Thermal Systems President Yoshihiro Ito.President Ito said: "We are proud that Empower has highly evaluated the performance and the quality of the after-sales service of the units previously delivered, and has once more chosen MHI Thermal Systems' chillers for these latest projects. We will continue improving energy efficiency while continuously enhancing operational and production effectiveness. We will continue implementing our advanced solutions to Empower's DCS plants so that our partnership will also contribute to the Dubai and the UAE's carbon emissions reduction strategy."Ahmad Bin Shafar emphasized that this deal offers both parties a significant opportunity to advance the district cooling sector and accelerate efforts toward a carbon-free future through energy-efficient solutions. He noted that these solutions reduce environmental impact and pave the way for a more sustainable tomorrow. Bin Shafar also highlighted that the agreement supports Empower's goal of upgrading its plants with innovative technologies that promote efficient, energy-saving production processes, aligning with the company's environmental and societal objectives and its commitment to safeguarding resources for future generations.Empower is responsible for more than 80% of Dubai's district cooling capacity, supplying chilled water for cooling from 87 district cooling plants, making it the world's largest district cooling services provider.MHI Thermal Systems, as a part of MHI Group, will continue to respond to customer needs and contribute to the realization of a carbon-neutral world through the supply of energy-efficient centrifugal chillers.(1) In terms of connected capacity(2) 1 refrigeration ton = approx. 3.516 kWAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.
Fujitsu and Teikyo University begin joint research on UX platform for promotion of lifestyle improvement using XR, spatial computing, and generative AI
TOKYO, Oct 18, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu and the Okinaga Research Institute at Teikyo University announced that, as of today, they will begin a full-scale joint research project for the development of a user experience (UX) platform. This platform will help to improve health consciousness and healthcare literacy by increasing patients’ understanding of their internal condition through the use of digital technology, such as extended reality (XR) and spatial computing (1).In this research project, Fujitsu and the Okinaga Research Institute will use XR and spatial computing to recreate a patient's internal anatomy in a virtual space, enhancing their understanding of the locations where health issues may arise. The two parties will examine how this visualization can foster health consciousness, behavioral change, and improved patient outcomes. The technology will be used in interviews with patients who have been advised to improve their lifestyle based on health check results. In addition, the two parties will also create an AI healthcare supporter avatar with generative AI technology to follow up with patients and will examine its effect on improving patient healthcare literacy.BackgroundIn recent years, lifestyle-related diseases have increased among both the elderly and younger populations. Preventing serious illness through lifestyle improvements is expected to reduce the national healthcare burden, improve corporate labor productivity, and enhance individual quality of life. Consequently, the Japanese Ministry of Health, Labour and Welfare requires health insurance societies to devise and implement data health plans. From this, effective improvements are being promoted through the plan-do-check-act (PDCA) cycle. In this cycle, data from the results of health checkups retained by health insurance societies and medical treatment bills are used to analyze the relationship between the data obtained from the medical examination and diseases to improve patient’s lifestyle.Improving lifestyles requires not only the support of healthcare providers but also a fundamental shift in individual mindset.In October 2022, Fujitsu and the Okinaga Research Institute started conducting research to eliminate the communication gap between doctors and patients by using XR, spatial computing, and generative AI in informed consent. This research led to the development such as virtual internal body models generated from patients’ biological data and technology for an AI medical supporter avatar. This research forms the basis of this latest project.Roles of Both Parties:1. Fujitsu- Conducting design research (2) with related parties and experts to identify hinderances to people’s awareness of true lifestyle improvement- Creating UX/UI scenarios for people to autonomously improve their lifestyles- Providing development support for an initial prototype, suggest improvements, and conduct a demonstration test with the prototype2. Okinaga Research Institute:- Providing medical expertise- Sharing visualization expertise in the area of medicine- Developing an initial prototype that uses organ dataFuture PlansBased on the results of this joint research project, Fujitsu and Teikyo University will contribute to improving people’s well-being and solving societal issues related to health by preventing lifestyle-related diseases through the societal implementation of health guidance that utilizes digital technology.(1) Spatial computing: A technology that seamlessly integrates physical and digital spaces, enabling people to interactively control information within that space.(2) Design research: Research with the aim of designing products and services from the user’s point of view. In this research, various information is collected and organized to identify potential customer needs and discover new issues and value.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press Contacts:Fujitsu LimitedPublic and Investor Relations DivisionInquiriesTeikyo UniversityHeadquarters Public Relations SectionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.
TANAKA to Provide Medals Representing the Event Concept with a Design of Gently Curved Circular Expansion for the Tokyo Legacy Half Marathon 2024
TOKYO, Oct 18, 2024 - (JCN Newswire via SeaPRwire.com) - TANAKA Holdings Co., Ltd. (Head office: Chuo-ku Tokyo; Group CEO: Koichiro Tanaka) will provide and donate gold, silver, and bronze medals to the top three finishers in the half marathon (elite athletes) and elite para-athletes (wheelchair and visual impairment) award categories at the Tokyo Legacy Half Marathon 2024. The Tokyo Legacy Half Marathon 2024 is organized by the Tokyo Marathon Foundation and will be held on October 20, 2024.*If the top three finishers above have a guide runner, a medal will also be provided to the guide runner.Medals Using Gently Expanding Curves to Represent the Event’s ConceptThe medals were designed based on the concept of the Tokyo Legacy Half Marathon: "We want to expand the opportunity for everyone to run, including those who have never run before, and create an event in which anyone can participate." The front of the medal features the event title, Tokyo Legacy Half Marathon 2024, written in English, and incorporates the event logo, which uses a motif of gently curved circles expanding outward. This logo represents the Earth’s continuous rotation, honoring the dedication of the runners who have trained tirelessly for 365 days leading up to the event. Additionally, the design of the Earth is reduced to about half the size of the medal to symbolize the half marathon.On the back of the medal, Tokyo Legacy Half 2024 is inscribed in braille, along with the TANAKA Precious Metals logo, and the word "FINISHER" and the event date. The ribbon is designed with the event logo, which resembles a tapestry of interwoven lines representing each runner, volunteer, and spectator.About the Tokyo Legacy Half Marathon 2024The Tokyo Legacy Half Marathon 2024 is a public participation half marathon (21.0975 km) that is half the distance of the Tokyo Marathon (42.195 km). It was born from the desire to create a half marathon that would give the extraordinary experience of running to everyone. This year, the event’s tagline is "If it’s a half marathon, I can barely make it, Maybe." aiming to offer a race where a wide variety of runners can enjoy the streets of Tokyo at their own pace.(Official website of the event: https://legacyhalf.tokyo/en/ )Since the inaugural event in 2022, TANAKA Precious Metals has been producing the medals awarded at the Tokyo Legacy Half Marathon, and this will be their third time providing them. In addition to the Tokyo Legacy Half Marathon, the company has also produced winner’s medals for the Tokyo Marathon, supported the promotion of para-sports as an official partner of the Japanese Para-Sports Association (JPSA), and manufactured and sold the official commemorative medals for the 1964 Tokyo Olympics. TANAKA Precious Metals will continue to produce medals made of precious metals and support the promotion of sports with the aim of contributing to the realization of a prosperous society.Overview of the Tokyo Legacy Half Marathon 2024 MedalsWeight, size and materialGold Medal: approx. 55g; approx. 55mm in diameter and approx. 2.3mm thick; pure silver with gold platingSilver Medal: approx. 55g; approx. 55mm in diameter and approx. 2.3mm thick; pure silverBronze Medal: approx. 45g; approx. 55mm in diameter and approx. 2.3mm thick; pure copper Race Information of the Tokyo Legacy Half Marathon 2024OrganizerTokyo Marathon FoundationCo-organizersTokyo Metropolitan Government; JAAF (Japan Association of Athletics Federations); Tokyo Sports Association for the DisabledManaging OrganizationTokyo Athletics AssociationOperation SupportJapan Para AthleticsSupporting OrganizationsJapan Industrial Track & Field AssociationOfficial PartnersSky Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; New Balance Japan, Inc.; Tokyo Tatemono Co., Ltd.; KINTETSU INTERNATIONAL; Hisamitsu Pharmaceutical Co.,Inc.; Tokyo Kiraboshi Financial Group, Inc.; TANAKA Holdings Co., Ltd.; Rokko Butter, Co., Ltd.; Photocreate Co.,Ltd.; SEIKO GROUP CORPORATIONOfficial SuppliersNIHON KOHDEN CORPORATION; Porsche Japan K.K.DateSunday, October 20, 2024 (rain or shine)Start/Finish AreaJapan National Stadium (Kasumigaoka-machi, Shinjuku, Tokyo) About TANAKA Precious MetalsSince its foundation in 1885, TANAKA Precious Metals has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,355 employees, the group’s consolidated net sales for the fiscal year ending December 2023, was 611.1 billion yen.TANAKA Holdings Websitehttps://www.tanaka.co.jp/english/Press inquiriesTANAKA Holdings Co., Ltd.https://tanaka-preciousmetals.com/en/inquiries-for-mediaPress Release: https://www.acnnewswire.com/docs/files/20241017.pdf Copyright 2024 JCN Newswire via SeaPRwire.com.
Participation in the Multilateral System Remains High as Performance Drops, New Index Finds
Washington, D.C., Oct 18, 2024 - (ACN Newswire via SeaPRwire.com) - Today marks the launch of the second edition of the Multilateralism Index from the International Peace Institute (IPI) and the Institute for Economics & Peace (IEP). The Index reveals that states remain engaged in the global multilateral system even as it increasingly struggles to address the crises it faces.Multilateralism Index 2024 ReportAn image of the front cover of the Multilateralism Index 2024 ReportKey resultsThe performance of the multilateral system declined across all five domains examined.Peace and security showed the steepest deterioration in performance, with the number of armed conflicts rising from 39 in 2013 to 55 in 2022.Climate action and human rights also saw significant declines in performance, despite increased engagement from member states.Participation in multilateral institutions has increased in most domains, even as performance has declined, indicating a shift from cooperation to contestation.Inclusivity improved across all domains, with steady growth in NGO engagement and women's representation in UN bodies.The Multilateralism Index 2024 presents a complex picture of global cooperation over the past decade, examining five crucial domains: Peace and Security, Human Rights, Climate Action, Public Health, and Trade. It reveals a contradiction: while participation in the multilateral system has largely held steady or even increased, its effectiveness in addressing global challenges has declined.Dr. Adam Lupel, IPI Vice President & COO said: "Over the past decade, we've witnessed a paradox in multilateralism. While participation in international institutions has largely held steady or even increased, the performance of the multilateral system in addressing global challenges has declined. This suggests a shift from cooperation to contestation at a time of transformation and rising global crises."The peace and security domain experienced the most significant deterioration in performance. Active armed conflicts increased from 39 in 2013 to 55 in 2022, with a notable rise in internationalized conflicts. The UN Security Council has seen more frequent use of the veto power, constraining its ability to respond to crises. However, states have not broadly pulled back from the UN peace and security architecture, and commitments in some areas, such as multilateral peacebuilding, have increased.Climate action presents another contradiction. Despite near-universal participation in the Paris Agreement and growing climate commitments, these commitments continue to fall short of necessary targets. Projections show an 8.8% increase in emissions by 2030, in stark contrast to the 43% decrease required to meet the critical 1.5°C target.The human rights domain exhibits a counterintuitive pattern. While engagement with UN human rights mechanisms has increased, global human rights protections have steadily declined. Most strikingly, members of the UN Human Rights Council consistently scored lower on human rights measures than the global average, indicating that many states are engaging less to advance human rights than to shape the direction of the system.Multilateral action on public health was significantly shaped by the COVID-19 pandemic, which reversed years of progress, particularly in areas such as childhood immunization. It also put the shortcomings of the global public health system in stark relief, spurring negotiations on an international pandemic agreement aimed at strengthening preparedness and response capabilities for future health crises.Trade is the one area where both performance and participation decreased. The paralysis of global trade negotiations and breakdown in adherence to global trade rules signal a shift away from multilateral approaches. This trend, combined with growing geopolitical tensions, creates challenges for global economic cooperation.Steve Killelea, Founder & Executive Chairman of IEP, commented: "The Multilateralism Index 2024 reveals a challenging trend: while engagement in global institutions has increased, their effectiveness has declined across key areas. There is a need to revitalize our multilateral system to address today's complex challenges."Despite these challenges, the Index highlights positive developments, particularly in the area of inclusivity. NGO engagement with the UN system has grown, and women's representation has increased across many UN bodies. However, the Global South remains underrepresented in many areas, suggesting that geographic inclusivity remains a work in progress.As the world contends with interconnected crises, from conflict to climate change, the Multilateralism Index 2024 provides valuable insights into the current state of global cooperation. It underscores the need for thoughtful reform to ensure that multilateral institutions can effectively address the complex challenges of the 21st century.Contact InformationMike KoslowskiIEP Senior Communications Advisormkoslowski@economicsandpeace.org+61418410531Related FilesMultilateralism Index 2024 - Full Press Release (1)Multilateralism Index 2024 - Full Press Release (1)SOURCE: International Peace Institute Copyright 2024 ACN Newswire via SeaPRwire.com.
DPC Dash – Domino’s Pizza China Drives Sales and Profit Growth and Optimizes Shareholder Structure
HONG KONG, Oct 18, 2024 - (ACN Newswire via SeaPRwire.com) - As recent economic stimulus measures by the government of China boost consumer confidence, and propel a rally in domestic stock markets, consumption stocks have been leading the surge, closing strong in the third quarter of 2024 strong. DPC Dash – Domino’s Pizza China, ("DPC Dash" or the "Company") (1405.HK), Domino's Pizza's exclusive master franchisee in the China Mainland, the Hong Kong Special Administrative Region of China, and the Macau Special Administrative Region of China, has further optimized shareholder structure to deliver long-term and significant value to shareholders.In the third quarter of 2024, the Company announced its inclusion in the Hong Kong Hang Seng Composite Index and the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs, underscoring its market credibility and growth potential. The inclusion in both a major index and stock connect programs offered more liquidity. As of October 15, 2024, the company’s stock price has surged over 60% since its IPO on March 28, 2023, significantly outperforming the Hang Seng Composite Index during the same period[i]. In order to further optimize shareholder structure and enhance the Company’s trading liquidity, Domino’s Pizza LLC, an indirect wholly-owned subsidiary of Domino’s Pizza, recently announced an agreement to sell an aggregate of 10,000,000 of the Company’s shares, or 7.66% of its total issued share capital as of October 17, 2024, to purchasers including institutional investors through off-market block trades. Following this share sale, Domino’s Pizza LLC retains 6.21% of total issued share capital with a lock-up period of 90 days for its remaining shares. The enduring relationship between DPC Dash and DPZ remains robust. The allocation is an opportunity for DPC Dash to further improve liquidity and bring new dynamics to its shareholder structure. Notable international banks have rated DPC Dash as “Buy” or “Outperform”, showing confidence in the company’s fundamentals and stock performance.DPC Dash continues to demonstrate its market prowess with strategic growth, operational efficiency and customer satisfaction. The Company’s remarkable success can be largely attributed to its effective 4D strategy of Development, Delicious pizza at value, Delivery, and Digital. This comprehensive approach has enabled the company to serve high-quality, value-for-money pizzas to a steadily growing customer base. From 2021 to 2023, DPC Dash realized a Compounded Annual Growth Rate (CAGR) of 37.6% in revenue. In the first half of 2024, revenue reached RMB2.04 billion while both reported and adjusted net profit after tax turned positive for the first time.The Company’s “Go Deeper, Go Broader” strategy has been instrumental in its growth. As of September 30, 2024, DPC Dash operates 978 stores across 33 cities, reflecting a robust expansion with 210 new stores opened year-to-date. The combined total of net new stores added this year, stores currently under construction, and stores with signed agreements has reached approximately 100% of the full-year opening target for 2024. It is confident in maintaining this strong expansion dynamic, with plans to open its 1000th store in the fourth quarter of 2024 and open 300 to 350 new stores annually in 2025 and 2026. The store network expansion is supported by strong performance metrics, including holding 28 of the top 30 positions for first 30-day sales among Domino’s global network of over 21,000 stores as of the end of the third quarter of 2024. Since the current management took the helm in the third quarter of 2017, DPC Dash has since achieved 29 consecutive quarters of positive same-store sales growth (SSSG) despite market and industrial turbulence. Meanwhile, the company’s digital initiatives played a crucial role in driving customer engagement and loyalty. The company’s loyalty program boasted 21.7 million members as of September 2024, with 11 million new customers placing their first orders in the past 12 months with Domino’s Pizza China.Looking ahead, DPC Dash remains focused on its expansion plans and operational enhancements, aiming for sustainable, profitable growth in China’s vast pizza market through continual innovation and optimization. The company’s resilient business model and strategic initiatives position it well for continued success in this competitive industry. The company will continue to strengthen its market position and add value to consumers by constantly enhancing product quality, service level, and customer experience.[i] Based on closed stock price of DPC Dash and HSCI of March 28, 2023 and October 15, 2024. Copyright 2024 ACN Newswire via SeaPRwire.com.
ผลสำรวจเยาวชนเยอรมันพบว่าส่วนใหญ่กลัวสงคราม
(SeaPRwire) - การศึกษาที่ดำเนินการโดย บริษัทน้ำมันเชลล์ แสดงให้เห็นว่า 81% ของผู้ตอบแบบสอบถามมีความกังวลเกี่ยวกับการเกิดความขัดแย้งทางทหารในยุโรป ผลสำรวจล่าสุดแสดงให้เห็นว่า คนหนุ่มสาวส่วนใหญ่ในเยอรมนีมีความกังวลเกี่ยวกับความเป็นไปได้ของสงครามครั้งใหญ่ในยุโรป การศึกษานี้ดำเนินการโดย บริษัทน้ำมันและก๊าซข้ามชาติของอังกฤษ เชลล์ อ้างถึงการค้นพบนี้โดยเฉพาะกับความขัดแย้งที่ดำเนินอยู่ระหว่างยูเครนกับรัสเซีย ในเดือนมิถุนายน โอลาฟ ชโตลซ์ นายกรัฐมนตรีเยอรมันอนุมัติแผนฉุกเฉินใหม่ของประเทศสำหรับสงครามที่อาจเกิดขึ้น – ซึ่งเป็นการอัปเดตครั้งแรกนับตั้งแต่ปี 1989 กรุงเบอร์ลินอ้างถึงภัยคุกคามที่รับรู้ได้จากรัสเซีย โดยกรอบการทำงานนี้คาดการณ์ถึงการฟื้นฟูการเกณฑ์ทหารภาคบังคับท่ามกลางมาตรการอื่นๆ ในเวลาเดียวกัน โบรริส พิสทอริอุส รัฐมนตรีว่าการกระทรวงกลาโหมบอกกับสมาชิกรัฐสภาว่า ประเทศต้อง “พร้อมสำหรับสงคราม” ภายในปี 2029 เขาเน้นย้ำถึงความสำคัญของการเพิ่มกำลังพลของกองทัพบกเยอรมัน แนะนำให้มีการนำการเกณฑ์ทหารกลับมาใช้บางส่วน ซึ่งถูกยกเลิกไปในปี 2011 การสำรวจความคิดเห็นที่เผยแพร่เมื่อวันจันทร์และมีชื่อว่า ‘ความปฏิบัติจริงระหว่างความสิ้นหวังและการกอดรับความหลากหลาย’ ได้วัดความคิดเห็นของชาวเยอรมัน 2,509 คนที่มีอายุระหว่าง 12 ถึง 25 ปี เกี่ยวกับประเด็นต่างๆ แสดงให้เห็นว่า “ความกลัวสงครามในยุโรป” เป็นความกังวลอันดับต้นๆ (81%) ในหมู่คนหนุ่มสาว ความกังวลทางเศรษฐกิจและความยากจนที่อาจเกิดขึ้นนั้นเป็นความกังวลอันดับสอง โดย 67% ของผู้ตอบแบบสอบถามแสดงความคิดเห็น นักวิจัยยังตั้งข้อสังเกตอีกว่า 55% ของผู้ตอบแบบสอบถามที่เป็นเยาวชนกล่าวว่าพวกเขาสนใจการเมือง ซึ่งเพิ่มขึ้นอย่างมากจาก 34% ในปี 2002 ในเดือนมกราคม พิสทอริอุส บอกกับสถานีโทรทัศน์สาธารณะ ZDF ว่าเยอรมนีควรเตรียมพร้อมที่จะ “ทำสงครามที่บังคับให้เราทำ” ในอนาคตและเตรียมอาวุธตอนนี้ ในเดือนกรกฎาคม วอชิงตันและกรุงเบอร์ลินตกลงกันว่า ขีปนาวุธล่องเรือของสหรัฐฯ จะถูกนำไปประจำการในเยอรมนีตั้งแต่ปี 2026 ตามที่หัวหน้าฝ่ายป้องกันประเทศเยอรมันกล่าวว่า การปรับใช้ตามแผนจะ “ให้เวลาที่เราต้องการ” เพื่อพัฒนาอาวุธที่คล้ายกันในประเทศ การกระทำดังกล่าวจะถูกห้ามไว้ก่อนหน้านี้ภายใต้สนธิสัญญาอาวุธนิวเคลียร์ระยะกลาง (INF) ในยุคสงครามเย็น ซึ่งวอชิงตันถอนตัวออกในปี 2019 เมื่อแสดงความคิดเห็นเกี่ยวกับการพัฒนาในเวลานั้น ประธานาธิบดีวลาดิมีร์ ปูตินแห่งรัสเซียเตือนว่า “หากสหรัฐฯ ดำเนินการตามแผนดังกล่าว เราจะพิจารณาตัวเองว่าไม่ถูกผูกมัดด้วยข้อห้ามที่เคยใช้มาก่อนในการปรับใช้ขีปนาวุธโจมตีระยะกลางและระยะสั้น” และกล่าวว่ารัสเซีย “จะใช้มาตรการสะท้อน” เพื่อปรับใช้ระบบเหล่านี้บทความนี้ให้บริการโดยผู้ให้บริการเนื้อหาภายนอก SeaPRwire (https://www.seaprwire.com/) ไม่ได้ให้การรับประกันหรือแถลงการณ์ใดๆ ที่เกี่ยวข้องกับบทความนี้ หมวดหมู่: ข่าวสําคัญ ข่าวประจําวัน SeaPRwire จัดส่งข่าวประชาสัมพันธ์สดให้กับบริษัทและสถาบัน โดยมียอดการเข้าถึงสื่อกว่า 6,500 แห่ง 86,000 บรรณาธิการและนักข่าว และเดสก์ท็อปอาชีพ 3.5 ล้านเครื่องทั่ว 90 ประเทศ SeaPRwire รองรับการเผยแพร่ข่าวประชาสัมพันธ์เป็นภาษาอังกฤษ เกาหลี ญี่ปุ่น อาหรับ จีนตัวย่อ จีนตัวเต็ม เวียดนาม ไทย อินโดนีเซีย มาเลเซีย เยอรมัน รัสเซีย ฝรั่งเศส สเปน โปรตุเกส และภาษาอื่นๆ
บริษัทผู้ผลิตขีปนาวุธ Patriot ถูกปรับเกือบ 1 พันล้านดอลลาร์
(SeaPRwire) - ผู้ผลิตขีปนาวุธ Patriot ถูกปรับเกือบ 1 พันล้านดอลลาร์ รัฐบาลสหรัฐฯ ได้สั่งให้ Raytheon ผู้รับเหมาด้านการป้องกันประเทศจ่ายค่าปรับมากกว่า 950 ล้านดอลลาร์สำหรับการบวมราคาสัญญาของรัฐบาลกลางและการติดสินบนเจ้าหน้าที่ทหารระดับสูงของต่างประเทศ โดยมีการประกาศเมื่อวันพุธที่ผ่านมา ตามเอกสารข่าวบนเว็บไซต์ของกระทรวงยุติธรรมของสหรัฐฯ Raytheon ซึ่งเป็นบริษัทในเครือของ RTX ไม่ได้โต้แย้งข้อกล่าวหา บริษัทได้ตกลงที่จะจ่ายค่าปรับและเข้าสู่ข้อตกลงการเลื่อนการดำเนินคดีเป็นเวลาสามปี (DPA) เกี่ยวกับข้อหาต่างๆ ซึ่งรวมถึงข้อหา “การฉ้อโกงที่ร้ายแรงต่อสหรัฐอเมริกา” สองข้อ “Raytheon ยอมรับว่าได้มีส่วนร่วมในโครงการแยกกันสองโครงการเพื่อฉ้อโกงกระทรวงกลาโหม (DOD) เกี่ยวกับการจัดหาอุปกรณ์และบริการด้านการป้องกันประเทศ รวมถึงระบบขีปนาวุธ PATRIOT และระบบเรดาร์” คำแถลงของกระทรวงยุติธรรมระบุ ตามที่อัยการกล่าวหา จากปี 2012 ถึงปี 2013 และอีกครั้งจากปี 2017 ถึงปี 2018 พนักงานของ Raytheon ได้ให้ “ข้อมูลเท็จและปลอมแปลง” แก่กระทรวงกลาโหมระหว่างการเจรจาสัญญาเกี่ยวกับการขายระบบขีปนาวุธ Patriot และการดำเนินงานและการบำรุงรักษาของระบบเรดาร์ ในทั้งสองกรณี อัยการกล่าวว่ากระทรวงกลาโหมถูกหลอกและลงท้ายด้วยการจ่ายเงินให้กับ Raytheon มากกว่าที่ควรจะจ่ายถึง 111 ล้านดอลลาร์ Raytheon ยังยอมรับว่าได้ให้ข้อมูลเท็จซ้ำแล้วซ้ำเล่ากับกระทรวงกลาโหมระหว่างปี 2009 ถึงปี 2020 เกี่ยวกับต้นทุนและการกำหนดราคาในสัญญาของรัฐบาลหลายฉบับ นอกจากนี้ ผู้ผลิตยังได้เข้าสู่ DPA แยกต่างหากเป็นเวลาสามปีอีกสองข้อหา ซึ่งรวมถึงการสมคบคิดเพื่อติดสินบนเจ้าหน้าที่ทหารระดับสูงของกาตาร์ และการสมคบคิดเพื่อละเมิดพระราชบัญญัติการควบคุมการส่งออกอาวุธ (AECA) เพื่อปกปิดสินบนในใบสมัครขอใบอนุญาตการส่งออกกับกระทรวงการต่างประเทศ Raytheon ยังกล่าวกันว่าได้บรรลุข้อตกลงการตั้งถิ่นฐานกฎหมายการอ้างสิทธิ์เท็จแยกต่างหากกับกระทรวงยุติธรรมที่เกี่ยวข้องกับโครงการกำหนดราคาที่มีข้อบกพร่อง “Raytheon มีส่วนร่วมในโครงการอาชญากรรมเพื่อฉ้อโกงรัฐบาลสหรัฐฯ เกี่ยวกับสัญญาสำหรับระบบทหารที่สำคัญและเพื่อชนะธุรกิจผ่านการติดสินบนในกาตาร์” รองอัยการสูงสุด Kevin Driscoll ของแผนกอาญาของกระทรวงยุติธรรมถูกอ้างว่ากล่าว “พฤติกรรมที่ทุจริตและฉ้อโกงเช่นนี้ โดยเฉพาะอย่างยิ่งโดยผู้รับเหมาด้านการป้องกันประเทศของสหรัฐฯ ที่จดทะเบียนในตลาดหลักทรัพย์ ทำให้ความเชื่อมั่นของสาธารณชนลดลงและเป็นอันตรายต่อ DOD ธุรกิจที่เล่นตามกฎ และผู้เสียภาษีอเมริกัน” Driscoll เพิ่มเติม ภายใต้ข้อตกลง DPA สองฉบับ Raytheon จะต้องว่าจ้างผู้ตรวจสอบการปฏิบัติตามกฎหมายอิสระเป็นเวลาสามปี ปรับปรุงโปรแกรมการปฏิบัติตามกฎหมายภายในของตน รายงานหลักฐานของการกระทำผิดเพิ่มเติม และให้ความร่วมมือในการสอบสวนทางอาญาที่ดำเนินการอยู่หรือในอนาคต กระทรวงยุติธรรมอธิบายบทความนี้ให้บริการโดยผู้ให้บริการเนื้อหาภายนอก SeaPRwire (https://www.seaprwire.com/) ไม่ได้ให้การรับประกันหรือแถลงการณ์ใดๆ ที่เกี่ยวข้องกับบทความนี้ หมวดหมู่: ข่าวสําคัญ ข่าวประจําวัน SeaPRwire จัดส่งข่าวประชาสัมพันธ์สดให้กับบริษัทและสถาบัน โดยมียอดการเข้าถึงสื่อกว่า 6,500 แห่ง 86,000 บรรณาธิการและนักข่าว และเดสก์ท็อปอาชีพ 3.5 ล้านเครื่องทั่ว 90 ประเทศ SeaPRwire รองรับการเผยแพร่ข่าวประชาสัมพันธ์เป็นภาษาอังกฤษ เกาหลี ญี่ปุ่น อาหรับ จีนตัวย่อ จีนตัวเต็ม เวียดนาม ไทย อินโดนีเซีย มาเลเซีย เยอรมัน รัสเซีย ฝรั่งเศส สเปน โปรตุเกส และภาษาอื่นๆ
Embracing the Future of Manufacturing with the 26th Edition of the South Africa Manufacturing Show
Johannesburg, South Africa, Oct 15, 2024 - (ACN Newswire via SeaPRwire.com) - In the rapidly evolving field of healthcare, technological advancements are continually transforming both medical education and the delivery of healthcare services. Innovative solutions, in the healthcare field, present new possibilities for enhancing learning, improving patient outcomes, and advancing medical practices. These cutting-edge methods allow students and healthcare professionals to gain a deeper understanding of complex medical concepts and sharpen essential skills. Simultaneously, they foster the growth of local industries, driving innovation and creating economic opportunities, while addressing critical healthcare needs in a more sustainable and efficient way.One such innovation is focused on revolutionising medical education and healthcare in South Africa through the application of advanced 3D printing technology. By utilising this state-of-the-art tool, students and professionals are gaining unprecedented opportunities to deepen their knowledge of human anatomy, hone their surgical skills, and enhance patient care. This not only raises the standard of education but also contributes to the growth of local manufacturing industries, promoting healthcare excellence and economic development. Moreover, it strengthens South Africa's manufacturing capabilities, particularly in the production of medical devices.This collaboration fosters innovation and empowers small and medium enterprises (SMMEs) to compete on a global scale. With a focus on customized medical solutions, the initiative supports local manufacturing, creating jobs, and building a sustainable medical device industry. By encouraging collaboration between academic institutions and businesses, the project enhances the manufacturing ecosystem and contributes to South Africa's overall economic growth while addressing vital healthcare needs.Overview of the event: 26th Edition of the South Africa Manufacturing ShowThe 26th Edition of the South Africa Manufacturing Show is part of a global series that has been held in over 10 cities across multiple continents in recent years. This exclusive, invitation-only in-person event, which will be held on November 21, 2024 in Qurtuba Convention Centre, Johannesburg is designed specifically for technology leaders from top businesses, institutions, and government officials representing South Africa’s manufacturing sector.The agenda for the South Africa Manufacturing Show has been carefully curated to pinpoint the essential strategies required for making informed business decisions, enhancing operational efficiency, and advancing digital culture. The Summit will gather more than 200 C-Level Executives, Directors, and Heads of Technology to explore the potential of AI, Web 3.0, IoT, Cyber Security, and other Fourth Industrial Revolution (4IR) technologies, providing the insights necessary to initiate meaningful change in the industry today.Who will attendPandelani Reuben Munyai, Group CIO, Transnet SOC Ltd.Dhevan Pillay, CEO, LTM Energy Group.Oltesh Thobias, Regional Chief Procurement & Contracts Officer, African Development Bank Group.Stavros Nicolaou, Group Senior Executive, Aspen Pharmacare Holdings Ltd.The event will cover topics like:From Factory to Future: Industry 4.0's Role in South Africa's Manufacturing Evolution.From Concept to Creation: The Synergy of AI, 3D Printing, and South African Innovation in Manufacturing.Powering South Africa's Green Industrial Revolution: Balancing Sustainability, Energy Resilience, and Manufacturing Growth.Unleashing Efficiency: Harnessing Data Analytics in Manufacturing Processes.Regional Manufacturing to Achieve Health Equity and Security on the African Continent.Building Supply Chain Agility: Crafting Resilient Supply Chains in South Africa.For more information on the 26th edition South Africa Manufacturing Show, click the LinkAbout ExitoExito, which means success in Spanish, embodies our commitment to the success of our customers. Each year, we host over 240 virtual and in-person conferences globally, bringing together audiences with world-class thought leaders and C-level executives across industries. Our meticulously crafted agendas, based on extensive research and valuable industry insights, facilitate business, knowledge transfer, deal flow, and impactful messaging for brands.For Media Enquiries, contact:Kasturi Nayak (Sr. Marketing Executive)Kasturi.nayak@exito-e.comEnquiry@exito-e.comExito Media Concepts Copyright 2024 ACN Newswire via SeaPRwire.com.
ผู้นำรัฐสมาชิกสหภาพยุโรป ระบุ ตอนนี้เป็น ‘ช่วงเวลาเลวร้ายที่สุด’ สำหรับเคียฟที่จะเริ่มการเจรจาสันติภาพ
(SeaPRwire) - วลาดิมีร์ ปูติน รู้สึกว่ารัสเซีย “เป็นฝ่ายที่แข็งแกร่งกว่า” ประธานาธิบดีลิทัวเนียได้โต้แย้ง ช่วงเวลาปัจจุบันในความขัดแย้งระหว่างรัสเซียและยูเครนเป็นช่วงเวลาที่ “แย่ที่สุด” สำหรับเคียฟที่จะเริ่มการเจรจา กับมอสโก ประธานาธิบดีของลิทัวเนีย กิตานัส นอสเอดา ได้แนะนำ กองกำลังรัสเซียได้รุกคืบอย่างต่อเนื่องในดอนบาสและส่วนอื่นๆ ของแนวหน้าตั้งแต่ต้นปี โดยยึดครองหลายสิบหมู่บ้าน รวมถึงเมืองยุทธศาสตร์ อฟเดียฟกา ในเดือนกุมภาพันธ์และฐานที่มั่นที่สำคัญของอูห์เลดาร์ เมื่อต้นเดือนนี้ อาณาเขตภายใต้การควบคุมของยูเครนในเขตคูสค์ของรัสเซีย ซึ่งกองกำลังเคียฟบุกโจมตีเมื่อต้นเดือนสิงหาคม ก็ลดลงในช่วงไม่กี่สัปดาห์ที่ผ่านมา ประธานาธิบดีรัสเซีย วลาดิมีร์ ปูติน “คิดว่าเขากำลังเอาชนะและผลักดันยูเครนเข้ามุม” นอสเอดา บอกกับนักข่าวเมื่อวันพฤหัสบดี ขณะเดินทางมาถึงการประชุมสุดยอดของผู้นำสหภาพยุโรปในบรัสเซลส์ “นี่เป็นช่วงเวลาที่แย่ที่สุดที่จะเริ่มการเจรจา เพราะเขารู้สึกว่ารัสเซียเป็นฝ่ายที่แข็งแกร่งกว่า” เขาพูดดังกล่าวโดยอ้างจากรอยเตอร์ ผู้นำยูเครน วลาดิมีร์ เซเลนสกี้ มีกำหนดกล่าวสุนทรพจน์ต่อที่ประชุมในบรัสเซลส์ในภายหลังของวันนี้ เพื่อส่งเสริมแผนการชัยชนะแบบที่เขาสร้างขึ้น เซเลนสกี้ นำเสนอข้อเสนอของเขาต่อรัฐสภายูเครนเมื่อวันพุธ โดยระบุว่าข้อเสนอเหล่านี้รวมถึงการเชิญเคียฟเข้าร่วมนาโตอย่างเร่งด่วน การยกเลิกข้อจำกัดในการใช้ อาวุธระยะไกลที่ฝ่ายตะวันตกจัดหาให้สำหรับการโจมตีดินแดนรัสเซียที่ได้รับการยอมรับในระดับนานาชาติ รวมถึงการปรับใช้ “แพ็คเกจการยับยั้งทางยุทธศาสตร์แบบไม่ใช้นิวเคลียร์แบบครอบคลุม” บนดินแดนยูเครน “แผนนี้สามารถนำไปใช้ได้ ขึ้นอยู่กับพันธมิตร ฉันเน้นย้ำ: บนพันธมิตร มันไม่ได้ขึ้นอยู่กับรัสเซียทั้งหมด” เขากล่าวอ้าง “ไม่มีอะไรใหม่ในนั้น” ประธานาธิบดีลิทัวเนีย กล่าวถึงแผนของเซเลนสกี้ “มีสิ่งที่เราต้องการทำแต่ทำไม่ได้ในระหว่างการประชุมสุดยอดวิลนีอุส [ในปี 2023] เกี่ยวกับการเชิญยูเครนเข้าร่วมนาโต และสิ่งเดียวกันก็เกิดขึ้นอีกครั้งในวอชิงตัน [ในเดือนกรกฎาคม]” “ตราบใดที่เราไม่ทำ เราอยู่ห่างจากชัยชนะมาก การเชื่อมโยงเชิงสาเหตุที่นี่เห็นได้ชัด” นอสเอดา ซึ่งเป็นผู้สนับสนุนยูเครนอย่างแข็งขันในช่วงความขัดแย้ง กล่าวเสริม มาเรีย ซาคารอวา โฆษกกระทรวงต่างประเทศรัสเซีย อธิบายข้อเสนอของเซเลนสกี้ว่าเป็น “ชุดสโลแกนที่ไม่สอดคล้องกัน” โดยกล่าวว่าข้อเสนอเหล่านั้นไม่ใช่ ‘แผนการชนะ’ แต่เป็น “แผนสำหรับความโชคร้ายของยูเครน” มากกว่า ในเดือนมิถุนายน วลาดิมีร์ ปูติน ประธานาธิบดีรัสเซีย ประกาศว่ามอสโกพร้อมที่จะหยุดการสู้รบและเริ่มการเจรจากับยูเครนทันที หากเคียฟยอมสละความทะเยอทะยานของนาโตอย่างเป็นทางการและถอนตัวออกจากสาธารณรัฐประชาชนโดเนตสค์และลูฮันสค์ รวมถึงจากเคอร์ซอนและซาปอโรเซีย เขตแดนที่เข้าร่วมรัสเซียหลังการลงประชามติในฤดูใบไม้ร่วงปี 2565 เซเลนสกี้ ปฏิเสธข้อเสนอนั้น โดยตราหน้ามันว่าเป็น “คำขาด” เครมลินกล่าวว่าเงื่อนไขเหล่านั้นไม่ได้อยู่ในตารางอีกต่อไปหลังจากยูเครนบุกเข้าไปในเขตคูสค์ของรัสเซียบทความนี้ให้บริการโดยผู้ให้บริการเนื้อหาภายนอก SeaPRwire (https://www.seaprwire.com/) ไม่ได้ให้การรับประกันหรือแถลงการณ์ใดๆ ที่เกี่ยวข้องกับบทความนี้ หมวดหมู่: ข่าวสําคัญ ข่าวประจําวัน SeaPRwire จัดส่งข่าวประชาสัมพันธ์สดให้กับบริษัทและสถาบัน โดยมียอดการเข้าถึงสื่อกว่า 6,500 แห่ง 86,000 บรรณาธิการและนักข่าว และเดสก์ท็อปอาชีพ 3.5 ล้านเครื่องทั่ว 90 ประเทศ SeaPRwire รองรับการเผยแพร่ข่าวประชาสัมพันธ์เป็นภาษาอังกฤษ เกาหลี ญี่ปุ่น อาหรับ จีนตัวย่อ จีนตัวเต็ม เวียดนาม ไทย อินโดนีเซีย มาเลเซีย เยอรมัน รัสเซีย ฝรั่งเศส สเปน โปรตุเกส และภาษาอื่นๆ
A Joint Regional Cohort Study by Shimadzu, Eisai, Oita University, and Usuki City Medical Association
Shimadzu Corporation, Eisai Co., Ltd., Oita University, and Usuki City Medical Association have demonstrated the utility of blood biomarkers in predicting the accumulation of amyloid beta (Aβ)(1) in the brain, a noted cause of Alzheimer’s disease(2), in a cohort study conducted in Usuki City, Oita from November 2022. A research paper reporting the details of this study was published on October 10, 2024, in the journal Alzheimer’s & Dementia: Translational Research & Clinical Interventions.This joint research attempts to develop Japan’s first diagnostic workflow for mild cognitive impairment (MCI) due to Alzheimer’s disease and mild dementia based on blood biomarkers. Comprising a phase 1 and phase 2 study, the phase 1 study uses frozen samples of blood plasma from a regional cohort collected by a prospective cohort study performed in Usuki City between 2015 and 2019 to evaluate the utility of blood biomarkers in predicting Aβ accumulation in the brain. The phase 2 study is a prospective study that uses blood plasma samples collected from 100 newly recruited subjects through diagnostic workflows adopted at all levels of health care, from primary care physicians to specialists certified by dementia-related societies, to evaluate the psychological impact on participants of different results and who discloses them.The research paper primarily compiles results from the phase 1 study. The ability of blood biomarkers to predict the results of amyloid PET scans(3) was evaluated in terms of an area under the curve (AUC) value. Blood biomarker measurements performed by Shimadzu resulted in an AUC value of 0.94 and identified PET-positive patients in the regional cohort with a high degree of accuracy. The joint research also revealed the possibility to predict the progression of clinical symptoms using baseline blood biomarker results, i.e., the progression from MCI due to Alzheimer's disease to Alzheimer's dementia from analysis of participant data over a seven-year observation period. Blood biomarker testing is less invasive than amyloid PET and cerebrospinal fluid testing(4), and could reduce patient stress and help predict the future onset of dementia if used as an alternative to these two diagnostic methods. The data collection stage of phase 2 is complete with plans in place to carry out data analysis and draft an overall report of the results of both phases of the joint research.The four parties involved in this joint research are committed to building an ecosystem that improves the early diagnosis of Alzheimer’s through diagnostic workflows adopted at all levels of health care from primary care physicians to specialists who are members of dementia-related societies, and through this research develop social infrastructure that ensures patients and their families live happy and fulfilling lives.Comment by Noriyuki Kimura, an Associate Professor at the Department of Neurology, Faculty of Medicine, Oita UniversityTreatment of Alzheimer’s disease is approaching a new turning point with the emergence of anti-amyloid beta antibodies that will require the diagnosis of Alzheimer’s disease at the MCI or early dementia stage. Biomarker-based tests to detect amyloid accumulation in the brain include amyloid PET scans and cerebrospinal fluid testing, but PET scans are expensive and cerebrospinal fluid testing is highly invasive. Blood biomarker testing is low-cost and less invasive, and its adoption promises to reduce the financial and physical burden on patients.(1) Amyloid beta is a protein believed to cause Alzheimer’s disease that accumulates in the brain to form senile plaques beginning around 20 years before the onset of Alzheimer’s disease.(2) Alzheimer’s disease is the most common cause of dementia and its key pathological hallmarks are senile plaques, neurofibrillary tangles, and neuronal cell death.(3) Amyloid PET is a brain imaging test that can visualize amyloid beta accumulation in the brain.(4) Cerebrospinal fluid testing collects cerebrospinal fluid and tests it for amyloid-β 42, amyloid-β 40, phosphorylated tau protein, and total tau protein, which are biomarkers of Alzheimer’s disease.Research Paper InformationJournal name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsTitle of paper: Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment.Authors: Takuya Ataka, Noriyuki Kimura, Naoki Kaneko, Teruaki Masuda, Yosuke Takeuchi, Kenichi Yabuuchi, Takeshi Mizukami, Tsukasa Takeuchi, Temmei Ito, Hideaki Tasai, Takehiko Miyagawa, Shunya Hanai, Shinichi Iwamoto, and Etsuro MatsubaraDOI: 10.1002/trc2.70008Related InformationNovember 22, 2022 Press releaseTo Develop Japan’s First Blood Biomarker-Based Diagnostic Workflow for DementiaShimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Researchwww.eisai.com/news/2022/news202280.html For Press and Media Inquiries, Please Contact:Shimadzu CorporationCorporate Communication Department Phone: +81-75-823-1110Eisai Co., Ltd.Public Relations Department Phone: +81-3-3817-5120Oita UniversityDepartment of Neurology, Faculty of Medicine Phone: +81-97-586-5814Usuki City Medical AssociationUsuki City Medical Association Office Phone: +81-972-63-0099 Copyright 2024 JCN Newswire via SeaPRwire.com.
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in Australia
TOKYO and CAMBRIDGE, Mass., Oct 17, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. announced today that the Therapeutic Goods Administration (TGA) of Australia issued a public statement about the initial decision not to register the humanized anti-solubleaggregated amyloid-beta (Aβ) monoclonal antibody lecanemab for the treatment of patients with mild cognitive impairment (MCI)due to Alzheimer’s disease (AD) and mild AD dementia.Eisai will request a reconsideration of this decision under Section 60* of the Therapeutic Goods Act within 90 days to make lecanemab available for eligible people living with early AD in Australia. Following Eisai’s request for review, the TGA will issue a final decision within 60 days of receiving Eisai’s request.Lecanemab is already approved in the United States, Japan, China, South Korea, Hong Kong, Israel UAE and Great Britain, and is being marketed in the U.S., Japan and China.Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision- making authority.*When we receive the outcome of the evaluation, Section 60 of the Australian legislation defines this as an “initial decision”. This is because the legislation states any decision considered an “initial decision” can be reviewed on request. This legislated process is referred to as a“request for a review of an initial decision” by the TGA. Note the specific part of the legislation that defines this is Section 60 of the Therapeutic Goods Act.About lecanemab (Leqembi®)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab is approved in the U.S., Japan, China, South Korea, Hong Kong, Israel, UAE and Great Britain for the treatment of MCI due to AD and mild AD dementia. Lecanemab’s approvals in these countries were primarily based on Phase 3 data from Eisai’s global Clarity AD clinical trial, in which it met its primary endpoint and all key secondary endpoints with statisticallysignificant results. The most common adverse events (>10%) in the lecanemab group were infusion reactions, ARIA-H (combined cerebral microhemorrhages, cerebral macrohemorrhages, and superficial siderosis), ARIA-E (edema/effusion), headache, and fall.Lecanemab is marketed in the U.S., Japan and China. Eisai has also submitted applications for approval of lecanemab in 10 countries and regions, including the European Union.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normaland have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti- amyloid therapy.About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisaiserves as the lead of lecanemab development and regulatory submissions globally with both companies co-commercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of AD treatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on theantibody back-up was signed in May 2015.About Eisai Co., Ltd.Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities,manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), by working on various activities together with global partners.For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), and connect with us on X, LinkedIn and Facebook. The website and social media channels are intendedfor audiences outside of the UK and Europe. For audiences based in the UK and Europe, please visit www.eisai.eu and Eisai EMEA LinkedIn.About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.The company routinely posts information that may be important to investors on its website at www.biogen.com.Follow Biogen on social media – Facebook, LinkedIn, X, YouTube.ContactsMEDIA CONTACT:Eisai Co., Ltd.Public Relations Department+81-(0)3-3817-5120Eisai Europe, Ltd.EMEA Communications Department+44 (0) 7974-879-419Emea-comms@eisai.netEisai Inc. (U.S.) Libby Holman+ 1-201-753-1945Libby_Holman@eisai.comMEDIA CONTACT:Biogen Inc. Jack Cox+ 1-781-464-3260public.affairs@biogen.comINVESTOR CONTACT:Biogen Inc. Stephen Amato+ 1-781-464-2442IR@biogen.comINVESTOR CONTACT:Eisai Co., Ltd.Investor Relations Department+81-(0)70-8688-9685Biogen Safe HarborThis news release contains forward-looking statements, about the potential clinical effects of lecanemab; the potential benefits, safety and efficacy of lecanemab; potential regulatory discussions, submissions and approvals and the timing thereof; thetreatment of Alzheimer's disease; the anticipated benefits and potential of Biogen's collaboration arrangements with Eisai; the potential of Biogen's commercial business and pipeline programs; including lecanemab; and risks and uncertainties associated with drug development and commercialization. These statements may be identified by words such as "aim," "anticipate," "believe," "could," "estimate," "expect," "forecast," "intend," "may," "plan," "possible," "potential," "will," "would" and other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small numberof research and development programs result in commercialization of a product. Results in early-stage clinical studies may notbe indicative of full results or results from later stage or larger scale clinical studies and do not ensure regulatory approval. You should not place undue reliance on these statements.These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements, including without limitation unexpected concerns that may arise from additional data, analysis or results obtained during clinical studies; the occurrence of adverse safety events; risks of unexpected costs or delays; the risk of other unexpected hurdles; regulatory submissions may take longer or be more difficult to complete than expected; regulatoryauthorities may require additional information or further studies, or may fail or refuse to approve or may delay approval of Biogen's drug candidates; including lecanemab; actual timing and content of submissions to and decisions made by the regulatory authorities regarding lecanemab; uncertainty of success in the development and potential commercialization of the medicine; failure to protect and enforce Biogen's data, intellectual property and other proprietary rights and uncertaintiesrelating to intellectual property claims and challenges; product liability claims; and third party collaboration risks, results ofoperations and financial condition. The foregoing sets forth many, but not all, of the factors that could cause actual results todiffer from Biogen's expectations in any forward-looking statement. Investors should consider this cautionary statement as wellas the risk factors identified in Biogen's most recent annual or quarterly report and in other reports Biogen has filed with the U.S.Securities and Exchange Commission. These statements speak only as of the date of this news release. Biogen does notundertake any obligation to publicly update any forward-looking statements. Copyright 2024 JCN Newswire via SeaPRwire.com.












